Processing 00000000.tx.1: End4/Sla2 is involved in establishment of a new growth zone in Schizosaccharomyces pombe Stefania Castagnetti1,*, Ralf Behrens2 and Paul Nurse3 1 Cell Cycle Lab Cancer Research UK, 44 Lincoln's Inn Field, London, WC2A 3PX, UK 2 Paul-Ehrlich-Institute, Paul-Ehrlich-Strae 51-59, 63225 Langen, Germany 3 Rockefeller University, 1230 York Avenue, New York, NY 10021, USA * Author for correspondence (e-mail: s.castagnetti{at}cancer.org.uk ) Accepted 7 February 2005  Summary Top Summary Introduction Materials and Methods Results Discussion References  The rod-shaped Schizosaccharomyces pombe cell grows in a polarized fashion from opposing ends. 

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "involved in establishment of a new growth zone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0027651:New growth [Neoplastic Process]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205314:New [Temporal Concept]
   744   C0220844:growth [Physiologic Function]
   744   C1314939:Involved [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1710706:Zone [Spatial Concept]
   744   C2911660:Growth [Activity]

Phrase: "in Schizosaccharomyces pombe Stefania Castagnetti1,"

Phrase: "*,"

Phrase: "Ralf Behrens2"

Phrase: "and"

Phrase: "Paul Nurse3 1 Cell Cycle Lab Cancer Research UK,"

Phrase: "44 Lincoln's Inn Field,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   812   C1521738:Field [Conceptual Entity]
   812   C2346620:Field [Conceptual Entity]
   812   C2349184:Field [Conceptual Entity]
   812   C3539073:FIELD [Spatial Concept]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "WC2A 3PX,"

Phrase: "UK 2 Paul-Ehrlich-Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021622:institute [Organization]
   804   C1272753:Institute [Idea or Concept]

Phrase: "Paul-Ehrlich-Strae 51-59,"

Phrase: "63225 Langen,"

Phrase: "Germany 3 Rockefeller University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1230 York Avenue,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10021,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "* Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "s."

Phrase: "castagnetti{at}cancer.org.uk"

Phrase: ")"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "7 February 2005  Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The rod-shaped Schizosaccharomyces pombe cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0206427:Rod cell [Cell]
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "grows in a polarized fashion"

Phrase: "from opposing ends."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.2: Correct positioning of the growth zones is directed by the polarity marker Tea1 located at the cell ends where actin patches accumulate and cell growth takes place. 

Phrase: "Correct positioning of the growth zones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0150305:positioning [Therapeutic or Preventive Procedure]
   753   C0733755:Positioning [Spatial Concept]
   753   C1561964:Positioning [Health Care Activity]

Phrase: "is"

Phrase: "directed by the polarity marker Tea1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005516:Marker [Clinical Attribute]
   753   C0596963:Polarity [Quantitative Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "located at the cell ends where actin patches"
Meta Candidates (Total=17; Excluded=8; Pruned=0; Remaining=9)
   754   C1166660:actin patch [Cell Component]
   754   C1656978:cell end [Cell Component]
   744   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cell [Cell]
   744   C0444930:ends [Spatial Concept]
   744   C0994894:Patches [Medical Device]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0332461:Patch [Finding]
   711 E C0445403:Patch [Biomedical or Dental Material]
   711 E C0991556:Patch [Medical Device]
   711 E C1305400:Patch [Medical Device]
   711 E C1533128:Patch [Biomedical or Dental Material]
   711 E C1706366:{Patch} [Quantitative Concept]
   711 E C1707974:Patch [Biomedical or Dental Material]
   711 E C2746065:End [Temporal Concept]

Phrase: "accumulate"

Phrase: "and"

Phrase: "cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.3: We show that the S. pombe homologue of Saccharomyces cerevisiae SLA2, a protein involved in cortical actin organization and endocytosis, provides a link between the polarity marker and the growth machinery. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the S. pombe homologue of Saccharomyces cerevisiae SLA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homologue [Gene or Genome]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in cortical actin organization"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "and"

Phrase: "endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a link between the polarity marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the growth machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.4: In wild-type fission yeast cells, this homologue End4/Sla2 is enriched at cell ends during interphase and localizes to a medial ring at cell division, mirroring the actin localization pattern throughout the cell cycle. 

Phrase: "In wild-type fission yeast cells,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   858   C0449475:type cell [Intellectual Product]
   840   C0178453:Yeast, Fission [Fungus]
   840   C2700289:Yeast Cells [Laboratory Procedure]
   804   C0007634:Cells [Cell]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "this homologue End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "enriched at cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0007634:Cell [Cell]
   790   C0359583:enriched [Food]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]

Phrase: "ends during interphase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021798:Interphase [Cell Function]
   790   C0444930:End [Spatial Concept]
   790   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "localizes to a medial ring"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1818663:medial ring [Cell Component]
   760   C0205098:Medial [Spatial Concept]
   760   C0392752:localize [Spatial Concept]
   760   C0521164:Ring [Spatial Concept]
   760   C1260969:Ring [Medical Device]
   760   C1705184:Ring [Medical Device]

Phrase: "at cell division,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007590:Cell division [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1293097:Division [Therapeutic or Preventive Procedure]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2919030:Division [Organization]
   861   C2919031:Division [Activity]

Phrase: "mirroring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181868:Mirror [Manufactured Object]
   966   C1706183:Mirror [Manufactured Object]

Phrase: "the actin localization pattern throughout the cell cycle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.5: Proper localization relies on membrane trafficking and is independent of both the actin and microtubule cytoskeletons. 

Phrase: "Proper localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "relies on membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025255:Membrane [Tissue]
   790   C0596901:Membrane [Cell Component]
   790   C1706182:Membrane [Manufactured Object]
   718 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "is independent of both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332291:Independent of [Functional Concept]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]

Phrase: "the actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "microtubule cytoskeletons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1166781:Microtubule cytoskeleton [Cell Component]
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.6: End4/Sla2 is required for the establishment of new polarised growth zones, and deletion of its C-terminal talin-like domain prevents the establishment of a new growth zone after cell fission. 

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "required for the establishment of new polarised growth zones,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0027651:New growth [Neoplastic Process]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0205314:New [Temporal Concept]
   742   C0220844:growth [Physiologic Function]
   742   C1514873:Required [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708   C1710706:Zone [Spatial Concept]

Phrase: "and"

Phrase: "deletion of its C-terminal talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the establishment of a new growth zone"

Phrase: "after cell fission."
Processing 00000000.tx.7: We propose that End4/Sla2 acts downstream of the polarity marker Tea1 and is implicated in the recruitment of the actin cytoskeleton to bring about polarised cell growth. 

Phrase: "We"

Phrase: "propose"

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "acts downstream of the polarity marker Tea1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0005516:Marker [Clinical Attribute]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0522506:Downstream [Spatial Concept]
   748   C0596963:Polarity [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "implicated in the recruitment of the actin cytoskeleton to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0025979:Actin Cytoskeleton [Cell Component]
   742   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010853:Cytoskeleton [Cell Component]
   742   C1748451:Cytoskeleton [Cell Component]
   742   C2949735:Recruitment [Activity]

Phrase: "bring about polarised cell growth."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007595:Cell Growth [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1269647:Cell [Cell]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2911660:Growth [Activity]
Processing 00000000.tx.8: Key words: End4/Sla2, fission yeast, Tea1, cell growth  Introduction Top Summary Introduction Materials and Methods Results Discussion References  Many cellular activities including motility, differentiation and division, depend on the ability of cells to become polarized, a process that generally requires assembly of a polarized actin cytoskeleton to target secretion, vesicular transport and growth. 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "End4/Sla2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "fission yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "Tea1,"

Phrase: "cell growth  Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Many cellular activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "motility,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007608:Motility [Cell Function]
  1000   C0678835:Motility [Laboratory or Test Result]
  1000   C1510470:Motility [Organism Function]
   928 E C1979933:Motile [Finding]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "division,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293097:Division [Therapeutic or Preventive Procedure]
  1000   C2919030:Division [Organization]
  1000   C2919031:Division [Activity]

Phrase: "depend on the ability of cells to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0007634:Cells [Cell]
   748   C0085732:Ability [Organism Attribute]
   748   C0725813:depend [Medical Device]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "become"

Phrase: "polarized,"

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that generally"

Phrase: "requires"

Phrase: "assembly of a polarized actin cytoskeleton to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1706853:Assembly [Activity]
   748   C1879748:Assembly [Manufactured Object]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "vesicular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1325417:vesicular transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]
Processing 00000000.tx.9: Understanding how this polarization is brought about is a key problem in cell biology. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "how"

Phrase: "this polarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0946292:Polarization [Clinical Attribute]

Phrase: "is"

Phrase: "brought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332302:brought [Functional Concept]

Phrase: "about"

Phrase: "is"

Phrase: "a key problem in cell biology."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   804   C0005532:Biology [Biomedical Occupation or Discipline]
   733 E C0205460:Biologic [Qualitative Concept]
   733 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.10: In the rod-shaped yeast Schizosaccharomyces pombe, polarity is expressed in the pattern of cell growth, which is restricted to the ends of the long axis of the cell. 

Phrase: "In the rod-shaped yeast Schizosaccharomyces pombe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0178453:Schizosaccharomyces pombe [Fungus]
   804   C0036361:Schizosaccharomyces [Fungus]

Phrase: "polarity"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0596963:Polarity [Quantitative Concept]
   928 E C0813983:polar [Quantitative Concept]
   900 E C0337815:Poles [Population Group]
   900 E C0935623:Pole [Body Location or Region]
   900 E C1418729:POLE [Gene or Genome]

Phrase: "is"

Phrase: "expressed in the pattern of cell growth,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   804   C0007595:growth of cell [Cell Function]
           Cell Growth
   804   C1623229:cell growth pattern [Cell Function]
           growth pattern
   774   C1156245:Growth pattern [Finding]
   748   C0007634:Cell [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0449774:Pattern [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2911660:Growth [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "restricted to the ends of the long axis of the cell."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   756   C0522487:Long axis [Spatial Concept]
   738   C0004457:Axis [Body Part, Organ, or Organ Component]
   738   C0007634:Cell [Cell]
   738   C0205166:Long [Qualitative Concept]
   738   C0443288:Restricted [Functional Concept]
   738   C0444930:ends [Spatial Concept]
   738   C0999597:Axis [Mammal]
   738   C1269647:Cell [Cell]
   738   C1522496:Axis [Spatial Concept]
   738   C1704653:Cell [Medical Device]
   738   C1706317:Long [Qualitative Concept]
   738   C1948049:Cell [Spatial Concept]
   737   C1656978:cell end [Cell Component]
   704 E C2746065:End [Temporal Concept]
Processing 00000000.tx.11: This controlled spatial organization depends on both the actin and microtubule cytoskeletons. 

Phrase: "This controlled spatial organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0029237:Organisation [Physiologic Function]
   827   C0029246:Organization [Organization]
   827   C0220885:organization [Qualitative Concept]
   827   C1300196:Organization [Functional Concept]
   827   C1522486:Organization [Professional or Occupational Group]

Phrase: "depends on both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]

Phrase: "the actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "microtubule cytoskeletons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1166781:Microtubule cytoskeleton [Cell Component]
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.12: F-actin is required for polarized growth, whilst the microtubular cytoskeleton is required to accurately position the growth zones at the opposite ends of the cell. 

Phrase: "F-actin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "is"

Phrase: "required for polarized growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1514873:Required [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "whilst"

Phrase: "the microtubular cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to accurately position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "the growth zones at the opposite ends of the cell."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1183408:Zone of cell [Cell Component]
           Cell zone
   706   C1710706:Zone [Spatial Concept]
Processing 00000000.tx.13: Actin is organized in cortical patches associated with the growing surfaces of the cell and interference with the actin cytoskeleton completely disrupts cell polarity, resulting in cells becoming round. 

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "is"

Phrase: "organized in cortical patches"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   770   C0994894:Patches [Medical Device]
   770   C1300196:Organized [Functional Concept]
   737 E C0332461:Patch [Finding]
   737 E C0445403:Patch [Biomedical or Dental Material]
   737 E C0991556:Patch [Medical Device]
   737 E C1305400:Patch [Medical Device]
   737 E C1533128:Patch [Biomedical or Dental Material]
   737 E C1706366:{Patch} [Quantitative Concept]
   737 E C1707974:Patch [Biomedical or Dental Material]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: "associated with the growing surfaces of the cell"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   782   C0699040:Surface of cell [Cell Component]
           cell associated
           Cell surface
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0007634:Cell [Cell]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711   C0205148:Surface [Spatial Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "interference with the actin cytoskeleton completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0521102:Interference [Qualitative Concept]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cell polarity,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0085304:Cell Polarity [Spatial Concept]
   950 E C2262962:cell pole [Cell Component]
   861   C0596963:Polarity [Quantitative Concept]
   789 E C0813983:polar [Quantitative Concept]
   761 E C0337815:Poles [Population Group]
   761 E C0935623:Pole [Body Location or Region]
   761 E C1418729:POLE [Gene or Genome]

Phrase: "resulting in cells"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   882   C0332294:Resulting in [Functional Concept]
   790   C0007634:Cells [Cell]
   790   C0678226:resulting [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2825142:Result [Finding]

Phrase: "becoming"

Phrase: "round."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Round [Spatial Concept]
Processing 00000000.tx.14: In contrast, disruption of the microtubule cytoskeleton results in mispositioning of the growth zones and leads to alterations in cell morphology (Hagan, 1998; Sawin and Nurse, 1998). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "disruption of the microtubule cytoskeleton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "results in mispositioning of the growth zones"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2825142:Result [Finding]
   748   C2911660:Growth [Activity]
   714   C1710706:Zone [Spatial Concept]

Phrase: "and"

Phrase: "leads to alterations in cell morphology"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0243091:cell morphology [Qualitative Concept]
   790   C1521816:Cell morphology [Clinical Attribute]
   790   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   753   C0007634:Cell [Cell]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0332437:Morphology [Qualitative Concept]
   753   C0543482:morphology [Spatial Concept]
   753   C0700329:Morphology, NOS [Finding]
   753   C0700619:Morphology [Biomedical Occupation or Discipline]
   753   C1269647:Cell [Cell]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   731   C1260954:Morphologic alteration [Anatomical Abnormality]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "(Hagan,"

Phrase: "1998"

Phrase: "; Sawin"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.15: During interphase, microtubules are organized in antiparallel bundles with the plus ends facing the tips of the cell where they deliver the polarity marker, Tea1 (Drummond and Cross, 2000; Hagan, 1998; Mata and Nurse, 1997). 

Phrase: "During interphase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021798:Interphase [Cell Function]

Phrase: "microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "are"

Phrase: "organized in antiparallel bundles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1300196:Organized [Functional Concept]

Phrase: "with the plus ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "facing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015450:Face [Body Location or Region]
   966   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "the tips of the cell where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C1656978:cell tip [Cell Component]
   753   C0339897:TIPS [Therapeutic or Preventive Procedure]
   719 E C1710425:Tip [Medical Device]
   719 E C3282898:Tip [Qualitative Concept]

Phrase: "they"

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "the polarity marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "Tea1"

Phrase: "(Drummond"

Phrase: "and"

Phrase: "Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "2000"

Phrase: "; Hagan,"

Phrase: "1998"

Phrase: "; Mata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.16: Cells lacking Tea1 still polarize growth but either fail to properly position the growth zones, which results in bending and branching of cells, or grow only from one end, leading to monopolar growth (Mata and Nurse, 1997). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "Tea1 still"

Phrase: "polarize"

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "either"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to properly position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "the growth zones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1710706:Zone [Spatial Concept]
   777 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "results in bending"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0011119:bending [Disease or Syndrome]
   790   C0700231:bending [Finding]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2584296:Bending [Physiologic Function]
   790   C2825142:Result [Finding]

Phrase: "and"

Phrase: "branching of cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205384:Branching [Spatial Concept]

Phrase: "or"

Phrase: "grow"

Phrase: "only from one end,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C0205447:One [Quantitative Concept]
   770   C0444930:End [Spatial Concept]
   770   C1720467:Only [Intellectual Product]
   770   C2746065:End [Temporal Concept]
   715 E C0205088:Terminal [Temporal Concept]
   715 E C1705314:Terminal [Manufactured Object]
   715 E C1705315:Terminal [Spatial Concept]

Phrase: "leading to monopolar growth"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C1752489:monopolar growth [Cell Function]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Mata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.17: In wild-type cells the pattern of growth changes during the cell cycle. 

Phrase: "In wild-type cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0449475:type cell [Intellectual Product]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "the pattern of growth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1156245:Growth pattern [Finding]
   819   C1623229:growth pattern [Cell Function]
   770   C0449774:Pattern [Spatial Concept]

Phrase: "changes during the cell cycle."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007586:Cell Cycle [Cell Function]
   806   C1155839:Cell Cycle [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705241:Change [Quantitative Concept]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.18: After cell division growth is monopolar, taking place exclusively at the `old' end, which was present in the previous cell cycle. 

Phrase: "After cell division growth"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   734   C0007590:Cell division [Cell Function]

Phrase: "is"

Phrase: "monopolar,"

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "exclusively at the `old' end,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0444930:End [Spatial Concept]
   760   C0580836:Old [Temporal Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "which"

Phrase: "was"

Phrase: "present in the previous cell cycle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.19: However once a minimal cell size requisite is met and DNA replication is completed, growth is activated at the opposite `new' end that was generated at cytokinesis. 

Phrase: "However once"

Phrase: "a minimal cell size requisite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514873:Requisite [Functional Concept]

Phrase: "is"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "and"

Phrase: "DNA replication"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0598312:DNA Replication [Genetic Function]
           Replication
  1000   C2984261:DNA replication [Functional Concept]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: ","

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "activated at the opposite `new'"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205314:New [Temporal Concept]
   760   C1521805:Opposite [Spatial Concept]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "that"

Phrase: "was"

Phrase: "generated at cytokinesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:Cytokinesis [Cell Function]
   790   C1330957:cytokinesis [Cell Function]
   790   C3146294:Generated [Activity]
Processing 00000000.tx.20: This transition from monopolar to bipolar growth is known as new end take off or NETO (Mitchison and Nurse, 1985), and represents a major morphogenetic transition in the fission yeast cell cycle. 

Phrase: "This transition from monopolar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C2700061:Transition [Activity]

Phrase: "to bipolar growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1326221:bipolar growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "known as new end take off"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C1657233:new end take off [Cell Function]
   753   C0205309:Known [Qualitative Concept]
   753   C0205314:New [Temporal Concept]
   753   C0444930:End [Spatial Concept]
   753   C1515187:Take [Health Care Activity]
   753   C2746065:End [Temporal Concept]

Phrase: "or"

Phrase: "NETO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657233:NETO [Cell Function]

Phrase: "(Mitchison"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1985"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major morphogenetic transition in the fission yeast cell cycle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C3544383:cell cycle transition [Cell Function]
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C2700061:Transition [Activity]
   722   C0225340:Transitional cell [Cell]
Processing 00000000.tx.21: We reasoned that understanding the mechanisms underlying NETO might reveal new links between the actin and microtubule cytoskeletons and illuminate their roles in the spatial organization of the cell. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "NETO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657233:NETO [Cell Function]

Phrase: "might"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "new links between the actin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "microtubule cytoskeletons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1166781:Microtubule cytoskeleton [Cell Component]
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]

Phrase: "and"

Phrase: "illuminate"

Phrase: "their roles in the spatial organization of the cell."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0035820:Roles [Social Behavior]
   708 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.22: Hence, we looked for homologues of known regulators of actin dynamics that might link actin organization to new end localization. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "looked for homologues of known regulators of actin dynamics"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0182953:regulators [Medical Device]
   742   C0205309:Known [Qualitative Concept]
   708   C0233426:look [Organism Attribute]
   708   C1334043:Homologue [Gene or Genome]
   708 E C1704734:Regulator [Medical Device]
   708 E C1704735:Regulator [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "actin organization to new end localization."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]
Processing 00000000.tx.23: One such regulator is Sc-SLA2, which is essential in budding yeast for the proper assembly and function of the cortical actin cytoskeleton and for the establishment of cell polarity (Holtzman et al., 1993). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182953:REGULATOR [Medical Device]
  1000   C1704734:Regulator [Medical Device]
  1000   C1704735:Regulator [Conceptual Entity]

Phrase: "is"

Phrase: "Sc-SLA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "essential in budding yeast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "for the proper assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "function of the cortical actin cytoskeleton"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and for the establishment of cell polarity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C1156002:establishment of cell polarity [Cell Function]
   778   C0085304:Cell Polarity [Spatial Concept]
   748   C0007634:Cell [Cell]
   748   C0596963:Polarity [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1515981:And [Idea or Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   738 E C2331651:Polar Cell [Cell]
   728 E C2262962:cell pole [Cell Component]

Phrase: "(Holtzman et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.24: Sc-SLA2 binds actin in vitro through its talin-like domain and partially colocalizes with cortical actin patches at the growing surface of the cell (McCann and Craig, 1997; Yang et al., 1999). 

Phrase: "Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "in vitro through its talin-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "partially"

Phrase: "colocalizes with cortical actin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: "patches at the growing surface of the cell"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   793   C0699040:Surface of cell [Cell Component]
           Cell surface
   744   C0007634:Cell [Cell]
   744   C0205148:Surface [Spatial Concept]
   744   C0332461:Patch [Finding]
   744   C0445403:Patch [Biomedical or Dental Material]
   744   C0991556:Patch [Medical Device]
   744   C0994894:Patches [Medical Device]
   744   C1269647:Cell [Cell]
   744   C1305400:Patch [Medical Device]
   744   C1533128:Patch [Biomedical or Dental Material]
   744   C1704653:Cell [Medical Device]
   744   C1706366:{Patch} [Quantitative Concept]
   744   C1707974:Patch [Biomedical or Dental Material]
   744   C1948049:Cell [Spatial Concept]

Phrase: "(McCann"

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "1997"

Phrase: "; Yang et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.25: Loss of Sc-SLA2 activity results in complete delocalization of cortical actin patches (Holtzman et al., 1993) as well as defects in the internalization step of endocytosis (Kaksonen et al., 2003; Raths et al., 1993). 

Phrase: "Loss of Sc-SLA2 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "results in complete delocalization of cortical actin patches"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   778   C1166660:actin cortical patch [Cell Component]
           actin patch
   744   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0001613:Cortical [Body Part, Organ, or Organ Component]
   744   C0007776:Cortical [Body Part, Organ, or Organ Component]
   744   C0022655:Cortical [Body Part, Organ, or Organ Component]
   744   C0205197:Complete [Qualitative Concept]
   744   C0725685:COMPLEAT [Food]
   744   C0994894:Patches [Medical Device]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   711 E C0332461:Patch [Finding]
   711 E C0445403:Patch [Biomedical or Dental Material]
   711 E C0991556:Patch [Medical Device]
   711 E C1305400:Patch [Medical Device]
   711 E C1533128:Patch [Biomedical or Dental Material]
   711 E C1706366:{Patch} [Quantitative Concept]
   711 E C1707974:Patch [Biomedical or Dental Material]

Phrase: "(Holtzman et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: "as well as"

Phrase: "defects in the internalization step of endocytosis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "(Kaksonen et al.,"

Phrase: "2003"

Phrase: "; Raths et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.26: Homologues of Sc-SLA2 have already been identified in humans as huntingtin interacting proteins (Hip1 and Hip1R), and it has been suggested that Sla2-related proteins link the endocytic machinery to the actin cytoskeleton (Engqvist-Goldstein et al., 1999). 

Phrase: "Homologues of Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1334043:Homologue [Gene or Genome]

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "identified in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086418:Humans [Human]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "as huntingtin interacting proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Hip1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415546:HIP1 [Gene or Genome]
  1000   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Hip1R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825475:HIP1R [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Sla2-related proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the endocytic machinery to the actin cytoskeleton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0337076:machinery [Manufactured Object]

Phrase: "(Engqvist-Goldstein et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.27: By interfering with membrane-actin cytoskeleton interactions (Kalchman et al., 1997), the loss of the huntingtin-Hip1R interaction might contribute to the neurodegenerative disorder observed in Huntington patients. 

Phrase: "By"

Phrase: "interfering with membrane-actin cytoskeleton interactions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0025979:Actin Cytoskeleton [Cell Component]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0010853:Cytoskeleton [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0521102:interfering [Qualitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C1748451:Cytoskeleton [Cell Component]
   719   C1704675:Interaction [Functional Concept]

Phrase: "(Kalchman et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "the loss of the huntingtin-Hip1R interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "might"

Phrase: "contribute to the neurodegenerative disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   760   C0012634:Disorder [Disease or Syndrome]
   760   C1880177:Contribute [Activity]

Phrase: "observed in Huntington patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.28: Here we show that the recently identified S. pombe orthologue of Sc-SLA2 (End4/Sla2) (Iwaki et al., 2004) is enriched at sites of actin accumulation in fission yeast, is required for polarized cell growth and organization of the cortical actin cytoskeleton and its localization at the new end depends on Tea1. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the recently identified S. pombe orthologue of Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1335144:Ortholog [Gene or Genome]

Phrase: "(End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: ")"

Phrase: "(Iwaki et al.,"

Phrase: "2004"

Phrase: ")"

Phrase: "is"

Phrase: "enriched at sites of actin accumulation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C2945843:Site of [Qualitative Concept]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205145:Sites [Spatial Concept]
   753   C0359583:enriched [Food]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "in fission yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "required for polarized cell growth"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C1155893:polarized cell growth [Cell Function]
   806   C0007595:Cell Growth [Cell Function]
   806   C0598102:polarized cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1269647:Cell [Cell]
   760   C1514873:Required [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "organization of the cortical actin cytoskeleton"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   864   C1326252:cortical actin cytoskeleton organisation [Cell Function]
   820   C1155966:actin cytoskeleton organisation [Cell Function]
   814   C1326255:cortical cytoskeleton organisation [Cell Function]
   783   C1155964:cytoskeleton organisation [Cell Function]
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "its localization at the new end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "depends on Tea1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]
Processing 00000000.tx.29: We conclude that End4/Sla2 is required at the new end to organize or activate a new growth zone.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "required at the new end to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205314:New [Temporal Concept]
   753   C0444930:End [Spatial Concept]
   753   C1514873:Required [Functional Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "organize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1300196:organize [Functional Concept]

Phrase: "or"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a new growth zone."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1710706:Zone [Spatial Concept]
   755 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0027651:New growth [Neoplastic Process]
Processing 00000000.tx.30: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion References  Strains and media All S. pombe strains used in this study are listed in Table 1. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "and"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "All S. pombe strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]
   734   C0178453:S pombe [Fungus]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "listed in Table 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.31: Standard methods were used for growth, transformation and genetic manipulations (Moreno et al., 1991). 

Phrase: "Standard methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "used for growth,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1273517:used [Finding]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]

Phrase: "and"

Phrase: "genetic manipulations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0178659:genetic manipulation [Molecular Biology Research Technique]
   861   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   861   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "(Moreno et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.32: All experiments, unless otherwise stated, were performed in YES (yeast extract with added 250 mg/l histidine, adenine, leucine and uridine). 

Phrase: "All experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ","

Phrase: "were"

Phrase: "performed in YES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0884358:Performed [Functional Concept]
   790   C1549445:Yes [Idea or Concept]
   790   C1705108:Yes [Conceptual Entity]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(yeast extract with added 250 mg/l histidine,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0873195:YEAST EXTRACT [Organic Chemical,Pharmacologic Substance]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C2828366:Extract [Substance]

Phrase: "adenine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "uridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.33: sla2, sla2-GFP and sla2talin were generated using a PCR-based method (Bahler et al., 1998) with a kanMX template and oligos with 60-80 nt long homology to sla2. 

Phrase: "sla2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424907:SLA2 [Gene or Genome]

Phrase: "sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "sla2talin"

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PCR-based method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(Bahler et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "with a kanMX template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0728990:TEMPLATE [Medical Device]
   861   C1514575:Template [Conceptual Entity]
   861   C1705542:Template [Idea or Concept]

Phrase: "and"

Phrase: "oligos with 60-80 nt long homology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0045143:oligos [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   714 E C0028953:Oligo [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to sla2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424907:SLA2 [Gene or Genome]
Processing 00000000.tx.34: Sla2R1083G was generated using the same approach, with an oligonucleotide bearing the point mutation. 

Phrase: "Sla2R1083G"

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "with an oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the point mutation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]
Processing 00000000.tx.35: All deletions, mutations and tagging were performed in a diploid strain and then sporulated to produce viable haploids. 

Phrase: "All deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "tagging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0037293:Tag [Neoplastic Process]
   966   C0181496:Tag [Manufactured Object]
   966   C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "performed in a diploid strain"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0012568:Diploid [Organism Attribute]
   760   C0080194:Strain [Injury or Poisoning]
   760   C0456178:strain [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   760   C1518614:Strain [Organism]
   760   C2987481:Strain [Mental Process]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sporulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "viable haploids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018590:Haploids [Quantitative Concept]
Processing 00000000.tx.36: Deletions and insertions were checked by PCR for presence of a KanMX cassette at the right locus. 

Phrase: "Deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "insertions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441587:insertions [Health Care Activity]
   966 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   966 E C1512796:Insertion [Genetic Function]
   966 E C1883719:Insertion [Functional Concept]

Phrase: "were"

Phrase: "checked by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1283174:Checked [Activity]

Phrase: "for presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a KanMX cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450240:Cassette [Medical Device]
   861   C1706210:Cassette [Manufactured Object]

Phrase: "at the right locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.37: Point mutants were confirmed by sequencing of genomic DNAs. 

Phrase: "Point mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "confirmed by sequencing of genomic DNAs."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   767   C0162326:DNA sequencing [Nucleotide Sequence]
   767   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   756   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   719   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.38: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.39: Strains used in this study  Actin and FM4-64 staining and immunofluorescence For actin staining, cells were fixed by adding formaldehyde (with a final concentration of 3.7%) to the medium for 25 minutes, washed twice with PEM (100 mM Pipes, 1 mM EGTA, 1 mM MgSO4, pH 6.9), permeabilized with 1% Triton X-100, washed twice with PEM and stained with Alexa Fluor 488-phalloidin (Molecular Probes). 

Phrase: "Strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "used in this study  Actin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   781   C0869040:study use [Research Activity]
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "FM4-64 staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0294936:FM4-64 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "immunofluorescence For actin staining,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed by adding formaldehyde"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]
   737   C1883712:Add [Functional Concept]

Phrase: "("

Phrase: "with a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 3.7%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "to the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "for 25 minutes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PEM (100 mM Pipes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719 E C1709545:PIPE [Pharmacologic Substance]
   719 E C2828033:Pipe [Manufactured Object]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mM MgSO4,"

Phrase: "pH 6.9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "permeabilized with 1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   753   C0242759:Triton [Geographic Area]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PEM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "stained with Alexa Fluor 488-phalloidin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   753   C0031312:Phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0235665:FLUOR [Pathologic Function]
   753   C1071616:Alexa [Plant]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.40: FM4-64 staining was performed as described by Brazer et al. 

Phrase: "FM4-64 staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0294936:FM4-64 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Brazer et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336113:Brazer [Professional or Occupational Group]
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.41: (Brazer et al., 2000). 

Phrase: "(Brazer et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.42: Briefly, cells were pelleted and resuspended in YES containing 10 nM FM4-64 (Molecular Probes). 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in YES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1549445:Yes [Idea or Concept]
   790   C1705108:Yes [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 nM FM4-64"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0294936:FM4-64 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0312860:NM [Cell Function]
   812   C1424293:FM4 [Gene or Genome]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.43: Cells were incubated at 4C for 30 minutes, then washed, resuspended in fresh YES medium at a concentration of 5x106 cells/ml and grown at 25C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 minutes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456693:/30 minutes [Temporal Concept]
  1000   C1442458:30 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "resuspended in fresh YES medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C1549445:Yes [Idea or Concept]
   760   C1705108:Yes [Conceptual Entity]
   760   C1705217:Medium [Substance]
   760   C2827486:Fresh [Body Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 5x106 cells/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "grown at 25C."
Processing 00000000.tx.44: Staining was monitored every 5 minutes for up to 2 hours using an Axioplan Zeiss microscope (546 nm). 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "every 5 minutes for"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C0585314:Every 5 minutes [Temporal Concept]
   819   C0558291:Every minute [Temporal Concept]
   819   C0886384:minute 5 [Therapeutic or Preventive Procedure]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]

Phrase: "up to 2 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Axioplan Zeiss microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]

Phrase: "(546 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.45: For immunofluorescence, cells were collected by filtration and fixed in 80C methanol for 8 minutes and processed as described previously (Alfa et al., 1993). 

Phrase: "For immunofluorescence,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected by filtration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016107:filtration [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fixed in 80C methanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 8 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Alfa et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.46: For microtubule detection, TAT1 (-tubulin; a kind gift from K. Gull) antibody was used at 1:200 dilution, and Alexa Fluor 546-linked anti-mouse (Molecular Probes) at 1:1000 was used as secondary antibody. 

Phrase: "For microtubule detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "TAT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1422674:TAT1 [Gene or Genome]
  1000   C1424697:TAT1 [Gene or Genome]

Phrase: "(-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: ";"

Phrase: "a kind gift from K. Gull"

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "200 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "and"

Phrase: "Alexa Fluor 546-linked anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "1000"

Phrase: "was"

Phrase: "used as secondary antibody."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.47: Photographs were taken using an Axioplan Zeiss microscope. 

Phrase: "Photographs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441468:Photographs [Manufactured Object]
  1000   C1548899:Photographs [Health Care Activity]
   893 E C0031749:Photographies [Occupational Activity]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Axioplan Zeiss microscope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]
Processing 00000000.tx.48: Latranculin A, MBC and brefeldin A treatments Cells were grown at 25C in YES to OD595 0.5. 

Phrase: "Latranculin A,"

Phrase: "MBC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   902   C0066233:methyl carbamate [Organic Chemical]
   812   C0005050:benzimidazole [Organic Chemical]
   812   C0006948:Carbamate [Organic Chemical]
   812   C0053183:benzimidazole [Organic Chemical]

Phrase: "and"

Phrase: "brefeldin A treatments Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown at 25C"

Phrase: "in YES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1549445:Yes [Idea or Concept]
  1000   C1705108:Yes [Conceptual Entity]

Phrase: "to OD595 0.5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.49: Methyl-2-benzimidazole-carbamate (MBC) and brefeldin A (BfA) were then added to the medium to a final concentration of 25 g/ml and 100 g/ml, respectively. 

Phrase: "Methyl-2-benzimidazole-carbamate (MBC)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   902   C0066233:methyl carbamate [Organic Chemical]
   812   C0005050:benzimidazole [Organic Chemical]
   812   C0006948:Carbamate [Organic Chemical]
   812   C0053183:benzimidazole [Organic Chemical]

Phrase: "and"

Phrase: "brefeldin A (BfA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 25 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.50: Sla2-GFP-expressing cells were fixed with 80C methanol and stained for tubulin. 

Phrase: "Sla2-GFP-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with 80C methanol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained for tubulin."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2937342:tubulin [Cell Component]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.51: Fluorescence from Sla2-GFP is very strong and was still visible after fixation. 

Phrase: "Fluorescence from Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "very strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "still visible after fixation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.52: For latranculin A (latA) treatment, Sla2-GFP-expressing cells were fixed to a coverslip coated with lectin (100 g/ml). 

Phrase: "For latranculin A (latA) treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C0521125:For [Qualitative Concept]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "Sla2-GFP-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed to a coverslip"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "coated with lectin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0023206:Lectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(100 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.53: Medium containing 40 M latA was flushed under the coverslip and time-lapse images were taken every 2 seconds. 

Phrase: "Medium containing 40 M latA"

Phrase: "was"

Phrase: "flushed under the coverslip"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0016382:flushed [Sign or Symptom]
   737 E C1696091:Flush [Functional Concept]

Phrase: "and"

Phrase: "time-lapse images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "every 2 seconds."
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   861   C0457385:seconds [Temporal Concept]
   827 E C0205436:Second [Quantitative Concept]
   827 E C0565930:/second [Quantitative Concept]
   827 E C1561503:second [Idea or Concept]
   827 E C1705190:Second [Qualitative Concept]
   777 E C0027627:secondary [Neoplastic Process]
   777 E C0175668:Secondary [Temporal Concept]
Processing 00000000.tx.54: For block and release experiments, cdc10-129 cells were blocked for 3 hours (unless otherwise stated) at the restrictive temperature (36C). 

Phrase: "For block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "release experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "cdc10-129 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked for 3 hours"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0439227:hours [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C0564385:/hour [Quantitative Concept]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "("

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ")"

Phrase: "at the restrictive temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "(36C"

Phrase: ")."
Processing 00000000.tx.55: Following drug addition (at appropriate concentrations as previously stated), cells were quickly released to the permissive temperature (25C) and samples for immunofluorescence and Sla2-GFP were taken at different time points. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "drug addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "("

Phrase: "at appropriate concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "previously"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "quickly"

Phrase: "released to the permissive temperature"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(25C"

Phrase: ")"

Phrase: "and"

Phrase: "samples for immunofluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "taken at different time points."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   773   C2348792:Time Point [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C3541383:Time [Temporal Concept]
   726 E C1515187:Take [Health Care Activity]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.56: For latA treatment, cells were filtered following the block and resuspended in 1/10 of the original volume in medium containing 40 M latA. 

Phrase: "For latA treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C0521125:For [Qualitative Concept]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "resuspended in 1/10"

Phrase: "of the original volume in medium containing 40 M latA."
Processing 00000000.tx.57: After 10 minutes cells were released to permissive temperature and stained after 30 minutes. 

Phrase: "After 10 minutes cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0456692:/10 minutes [Temporal Concept]
   734   C1442446:10 Minutes [Temporal Concept]

Phrase: "were"

Phrase: "released to permissive temperature"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "stained after 30 minutes."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0456693:/30 minutes [Temporal Concept]
   833   C1442458:30 Minutes [Temporal Concept]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.58: LatA pulse experiments were performed as described by Rupes et al. 

Phrase: "LatA pulse experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Rupes et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.59: (Rupes et al., 1999). 

Phrase: "(Rupes et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.60: Briefly, cells were blocked at restrictive temperature for 3 hours. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked at restrictive temperature"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0005903:temperature [Organism Attribute]
   770   C0028778:Blocked [Pathologic Function]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "for 3 hours."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.61: Aliquots were filtered and resuspended in 1/10 volume of medium containing 40 M latA for 6 minutes at 36C. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "resuspended in 1/10 volume of medium containing 40 M latA"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   751   C0213052:M 40 [Amino Acid, Peptide, or Protein]
   736   C0009458:Medium [Intellectual Product]
   736   C0332256:Containing [Functional Concept]
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0439509:/40 [Temporal Concept]
   736   C0439536:Medium [Quantitative Concept]
   736   C0441923:M+ [Intellectual Product]
   736   C0449468:*Volume [Quantitative Concept]
   736   C1690016:% volume [Qualitative Concept]
   736   C1705102:Volume [Intellectual Product]
   736   C1705217:Medium [Substance]
   736   C2700258:Volume [Laboratory Procedure]
   736   C2700400:Containing [Activity]
   736   C3244283:medium [Intellectual Product]

Phrase: "for 6 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at 36C."
Processing 00000000.tx.62: LatA was then washed out by filtration, cells were washed with preconditioned medium and resuspended in fresh medium. 

Phrase: "LatA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064677:LAT-A [Organic Chemical]

Phrase: "was"

Phrase: "then washed out by filtration,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0392674:Washed out [Sign or Symptom]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1548982:Washed [Idea or Concept]
   726 E C0441648:Wash [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with preconditioned medium"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1548982:Washed [Idea or Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0441648:Wash [Activity]
   737   C0871117:precondition [Mental Process]
   737   C1709632:Precondition [Conceptual Entity]

Phrase: "and"

Phrase: "resuspended in fresh medium."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1705217:Medium [Substance]
   770   C2827486:Fresh [Body Substance]
   770   C3244283:medium [Intellectual Product]
Processing 00000000.tx.63: Cells were fixed for actin staining at 30-minute time intervals.  

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed for actin staining"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C2827483:Fixed [Body Substance]

Phrase: "at 30-minute time intervals."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   827   C0872291:Time Interval [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1272706:intervals [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.64: Results Top Summary Introduction Materials and Methods Results Discussion References  End4/Sla2 is involved in actin organization We identified the sla2 gene in the S. pombe genome database by homology with the S. cerevisiae sla2 gene. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "involved in actin organization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0029237:Organisation [Physiologic Function]
   770   C0029246:Organization [Organization]
   770   C0220885:organization [Qualitative Concept]
   770   C1300196:Organization [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1522486:Organization [Professional or Occupational Group]

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the sla2 gene in the S. pombe genome database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1424907:SLA2 gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "by homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334043:Homology [Gene or Genome]
  1000   C2697616:Homology [Qualitative Concept]

Phrase: "with the S. cerevisiae sla2 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1424907:SLA2 gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.65: S. pombe sla2 (SPAC688.11) encodes a protein with a predicted molecular mass of 123 kDa. 

Phrase: "S. pombe sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1424907:SLA2 [Gene or Genome]
   734   C0178453:S pombe [Fungus]

Phrase: "(SPAC688.11"

Phrase: ")"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a protein with a predicted molecular mass of 123 kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.66: Sequence alignment with other Sla2-related proteins showed that End4/Sla2 shares 36% similarity with Sc-SLA2 and 26% similarity with human HIP1R. 

Phrase: "Sequence alignment with other Sla2-related proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   748   C1706765:Alignment [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "36% similarity with Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "26% similarity with human HIP1R."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.67: End4/Sla2 has the same domain structure and organization as the other Sla2-related proteins, namely an N-terminal ENTH (epsin N-terminal homology) domain, a central coiled coil region, and a C-terminal talin-like domain. 

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "has"

Phrase: "the same domain structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0678594:Structure [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "organization as the"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0029237:Organisation [Physiologic Function]
   790   C0029246:Organization [Organization]
   790   C0220885:organization [Qualitative Concept]
   790   C1300196:Organization [Functional Concept]
   790   C1522486:Organization [Professional or Occupational Group]

Phrase: "other Sla2-related proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "namely"

Phrase: "an N-terminal ENTH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1824745:ENTH [Gene or Genome]

Phrase: "(epsin N-terminal homology) domain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1334043:Homology [Gene or Genome]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C2697616:Homology [Qualitative Concept]
   804   C3541951:Domain [Intellectual Product]

Phrase: "a central coiled coil region,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0454907:Central region [Geographic Area]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "a C-terminal talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1420760:TALIN [Gene or Genome]

Phrase: "like domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.68: The talin-like domain contains the I/LWEQ-module predicted to bind to F-actin (McCann and Craig, 1999). 

Phrase: "The talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the I/LWEQ-module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709061:Module [Conceptual Entity]
   727 E C1031041:Modulus [Eukaryote]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to F-actin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1622186:F-actin [Cell Component]
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "(McCann"

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.69: sla2 was deleted in a wild-type diploid using a PCR-based approach (Bahler et al., 1998). 

Phrase: "sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424907:SLA2 [Gene or Genome]

Phrase: "was"

Phrase: "deleted in a wild-type diploid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0012568:Diploid [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1880274:Deleted [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PCR-based approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "(Bahler et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.70: As in S. cerevisiae, sla2 cells were temperature sensitive for growth; 

Phrase: "As in S. cerevisiae,"

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "temperature sensitive for growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0332324:Sensitive [Functional Concept]
   770   C1550474:sensitive [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.71: cells failed to grow at 36C and at 32C, and grew slowly at 25C with a doubling time of about 6 hours, more than twice that of wild-type cells (2 hours 50 minutes). 

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow at 36C"

Phrase: "and at 32C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "grew"

Phrase: "slowly at 25C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439834:Slowly [Qualitative Concept]

Phrase: "with a doubling time"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C2986483:Doubling Time [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0205173:doubling [Functional Concept]
   861   C1705764:Doubling [Activity]
   861   C3541383:Time [Temporal Concept]
   827 E C1705765:Double [Qualitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of about 6 hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "more than twice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205172:More [Functional Concept]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "that of wild-type cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   824   C0449475:Type of cell [Intellectual Product]
           cells type
   806   C1883559:Wild Type [Organism Attribute]
   781 E C0007634:Cell Type [Cell]
           Cells
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(2 hours 50 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0439232:minute [Temporal Concept]
   812   C0700321:minute [Quantitative Concept]
   812   C0702093:/minute [Temporal Concept]
   812   C1282918:Minute [Quantitative Concept]
   812   C2347166:Minute [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.72: sla2 cells grown at 25C were wider than wild-type cells and showed a variety of growth patterns: cells were often branched, swollen in their middle regions or exhibited a complete loss of polarity (Fig. 1). 

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "grown at 25C"

Phrase: "were"

Phrase: "wider than wild-type cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332464:Wide [Spatial Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a variety of growth patterns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: ":"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "branched"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1253959:branched [Body Part, Organ, or Organ Component]
  1000   C2700384:Branched [Spatial Concept]
   966 E C1881507:Branch [Chemical Viewed Structurally]
   966 E C2700383:Branch [Plant]
   966 E C2826234:BRANCH [Intellectual Product]

Phrase: ","

Phrase: "swollen in their middle regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038999:Swollen [Finding]

Phrase: "or"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a complete loss of polarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.73: View larger version (57K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.74: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.75: sla2 cells have an aberrant morphology. 

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "an aberrant morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.76: (A) Morphological phenotype, (B) microtubules, (C) distribution of actin patches, (D) Tea1-GFP localization in wild type (upper panels) and sla2 (lower panels) grown at 25C. 

Phrase: "(A) Morphological phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(B) microtubules,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1516099:B-Microtubule [Cell Component]
   861   C0026046:Microtubules [Cell Component]

Phrase: "(C) distribution of actin patches,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
   756   C0205413:Patchy distribution [Qualitative Concept]

Phrase: "("

Phrase: "D)"

Phrase: "Tea1-GFP localization in wild type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "(upper panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424907:SLA2 [Gene or Genome]

Phrase: "(lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "grown at 25C."
Processing 00000000.tx.77: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.78: sla2 cells had an aberrant actin cytoskeleton. 

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "an aberrant actin cytoskeleton."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0025979:Actin Cytoskeleton [Cell Component]
   827   C0010853:Cytoskeleton [Cell Component]
   827   C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.79: In wild-type interphase cells, F-actin is organized in polarized cortical patches enriched at growing tips and in thin cables running along the main axis of the cell (Marks and Hyams, 1985). 

Phrase: "In wild-type interphase cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0449475:type cell [Intellectual Product]
   844   C1512899:Interphase Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "F-actin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "is"

Phrase: "organized in polarized cortical patches"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0994894:Patches [Medical Device]
   760   C1300196:Organized [Functional Concept]
   726 E C0332461:Patch [Finding]
   726 E C0445403:Patch [Biomedical or Dental Material]
   726 E C0991556:Patch [Medical Device]
   726 E C1305400:Patch [Medical Device]
   726 E C1533128:Patch [Biomedical or Dental Material]
   726 E C1706366:{Patch} [Quantitative Concept]
   726 E C1707974:Patch [Biomedical or Dental Material]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "enriched at growing tips"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0339897:TIPS [Therapeutic or Preventive Procedure]
   770   C0359583:enriched [Food]
   737 E C1710425:Tip [Medical Device]
   737 E C3282898:Tip [Qualitative Concept]

Phrase: "and in thin cables"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205168:Thin [Qualitative Concept]
   770   C0492124:cables [Medical Device]
   770   C1428446:CABLES [Gene or Genome]
   770   C1515981:And [Idea or Concept]

Phrase: "running along the main axis of the cell"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   744   C0004457:Axis [Body Part, Organ, or Organ Component]
   744   C0007634:Cell [Cell]
   744   C0035953:Running [Daily or Recreational Activity]
   744   C0205225:Main [Qualitative Concept]
   744   C0999597:Axis [Mammal]
   744   C1269647:Cell [Cell]
   744   C1522496:Axis [Spatial Concept]
   744   C1542147:Main [Qualitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2346414:Running [Finding]
   711 E C0600140:run [Finding]
   711 E C1704688:Run [Functional Concept]

Phrase: "(Marks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "and"

Phrase: "Hyams,"

Phrase: "1985"

Phrase: ")."
Processing 00000000.tx.80: In contrast, about half of sla2 cells at 25C showed misoriented cables (data not shown) and disorganized cortical structures, with actin patches delocalized throughout the cell body (Fig. 1C). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "about half of sla2 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1424907:SLA2 [Gene or Genome]
   760   C2825407:Half [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at 25C"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "misoriented cables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0492124:cables [Medical Device]
   861   C1428446:CABLES [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "disorganized cortical structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "with actin patches"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   983   C1166660:actin patch [Cell Component]
   861   C0994894:Patches [Medical Device]
   827 E C0332461:Patch [Finding]
   827 E C0445403:Patch [Biomedical or Dental Material]
   827 E C0991556:Patch [Medical Device]
   827 E C1305400:Patch [Medical Device]
   827 E C1533128:Patch [Biomedical or Dental Material]
   827 E C1706366:{Patch} [Quantitative Concept]
   827 E C1707974:Patch [Biomedical or Dental Material]
   777 E C0205413:Patchy [Qualitative Concept]

Phrase: "delocalized throughout the cell body"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0599444:Cell body [Cell Component]
   806   C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.81: In the cells, which maintained the normal rod shape at 25C, actin patches were observed only at one end (data not shown). 

Phrase: "In the cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "the normal rod shape at 25C,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1947942:Rod Shape [Spatial Concept]
   783   C0332480:Normal shape [Spatial Concept]
   753   C0332479:Shape [Spatial Concept]
   753   C0348078:shape [Qualitative Concept]
   753   C0522512:Shape [Spatial Concept]

Phrase: "actin patches"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   983   C1166660:actin patch [Cell Component]
   861   C0994894:Patches [Medical Device]
   827 E C0332461:Patch [Finding]
   827 E C0445403:Patch [Biomedical or Dental Material]
   827 E C0991556:Patch [Medical Device]
   827 E C1305400:Patch [Medical Device]
   827 E C1533128:Patch [Biomedical or Dental Material]
   827 E C1706366:{Patch} [Quantitative Concept]
   827 E C1707974:Patch [Biomedical or Dental Material]
   777 E C0205413:Patchy [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only at one end (data"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205171:Only [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0444930:End [Spatial Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1720467:Only [Intellectual Product]
   760   C2746065:End [Temporal Concept]
   760   C3245479:data [Medical Device]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: After shifting to 36C for 2 hours, sla2 cells became round and swollen and the actin patches became completely delocalized around the cortex, and medial rings could no longer be detected (Table 2). 

Phrase: "After shifting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333051:shifting [Functional Concept]

Phrase: "to 36C"

Phrase: "for 2 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "became"

Phrase: "round"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "swollen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038999:Swollen [Finding]

Phrase: "and"

Phrase: "the actin patches"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   983   C1166660:actin patch [Cell Component]
   861   C0994894:Patches [Medical Device]
   827 E C0332461:Patch [Finding]
   827 E C0445403:Patch [Biomedical or Dental Material]
   827 E C0991556:Patch [Medical Device]
   827 E C1305400:Patch [Medical Device]
   827 E C1533128:Patch [Biomedical or Dental Material]
   827 E C1706366:{Patch} [Quantitative Concept]
   827 E C1707974:Patch [Biomedical or Dental Material]
   777 E C0205413:Patchy [Qualitative Concept]

Phrase: "became"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "delocalized around the cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "medial rings"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1818663:medial ring [Cell Component]
   861   C1260969:Rings [Medical Device]
   827 E C0521164:Ring [Spatial Concept]
   827 E C1705184:Ring [Medical Device]

Phrase: "could"

Phrase: "no longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: sla2 cells with extreme polarity defects had microtubules curling under the cortex (data not shown). 

Phrase: "sla2 cells with extreme polarity defects"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   767   C0085304:Cell Polarity [Spatial Concept]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   748 E C2331651:Polar Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   717 E C2262962:cell pole [Cell Component]

Phrase: "had"

Phrase: "microtubules curling under the cortex"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: However, at 25C cells that still retained polarity showed a normal microtubule cytoskeleton, with three to four bundles running along the main axis of the cell (Fig. 1B). 

Phrase: "However,"

Phrase: "at 25C cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that still retained polarity"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0596963:Polarity [Quantitative Concept]
   755 E C0813983:polar [Quantitative Concept]
   727 E C0337815:Poles [Population Group]
   727 E C0935623:Pole [Body Location or Region]
   727 E C1418729:POLE [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a normal microtubule cytoskeleton,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1166781:Microtubule cytoskeleton [Cell Component]
   827   C0010853:Cytoskeleton [Cell Component]
   827   C1748451:Cytoskeleton [Cell Component]

Phrase: "with three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to four bundles"

Phrase: "running along the main axis of the cell"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   744   C0004457:Axis [Body Part, Organ, or Organ Component]
   744   C0007634:Cell [Cell]
   744   C0035953:Running [Daily or Recreational Activity]
   744   C0205225:Main [Qualitative Concept]
   744   C0999597:Axis [Mammal]
   744   C1269647:Cell [Cell]
   744   C1522496:Axis [Spatial Concept]
   744   C1542147:Main [Qualitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2346414:Running [Finding]
   711 E C0600140:run [Finding]
   711 E C1704688:Run [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: In these cells, Tea1 accumulated at opposite ends, as in wild-type cells (Fig. 1D). 

Phrase: "In these cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Tea1"

Phrase: "accumulated at opposite ends,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0444930:ends [Spatial Concept]
   770   C1521805:Opposite [Spatial Concept]
   737 E C2746065:End [Temporal Concept]

Phrase: "as in wild-type cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   797   C0449475:cells type [Intellectual Product]
   781 E C0007634:Cell Type [Cell]
           Cells
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.86: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.87: Actin distribution in wild type and sla2 cells  To investigate further the role of End4/Sla2 in actin organization, we generated a talin deletion of End4/Sla2. 

Phrase: "Actin distribution in wild type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "sla2 cells  To"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the role of End4/Sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in actin organization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a talin deletion of End4/Sla2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
Processing 00000000.tx.88: As the talin-like domain is dispensable for most Sc-SLA2 functions in S. cerevisiae (Wesp et al., 1997), we reasoned that this deletion might specifically interfere with actin regulation. 

Phrase: "As the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "dispensable for most Sc-SLA2"

Phrase: "functions in S. cerevisiae"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "(Wesp et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that"

Phrase: "this deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "might"

Phrase: "specifically"

Phrase: "interfere with actin regulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.89: A strain bearing a talin-truncated version of End4/Sla2 (sla2talin) was viable at all temperatures and grew at rates similar to those of wild type. 

Phrase: "A strain"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]
   805 E C0180860:Filter [Manufactured Object]
   805 E C0581406:Filter [Medical Device]
   805 E C1522664:Filter [Intellectual Product]
   805 E C1704449:Filter [Conceptual Entity]
   805 E C1704684:Filter [Medical Device]
   805 E C1875155:FILTER [Medical Device]
   777 E C0442694:Straining [Physiologic Function]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a talin-truncated version of End4/Sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "(sla2talin"

Phrase: ")"

Phrase: "was"

Phrase: "viable at all temperatures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "grew at rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "similar to those of wild type."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.90: As in budding yeast (Wesp et al., 1997; Yang et al., 1999), no obvious difference in bulk lipid endocytosis (by up-take of the lipophilic steryl dye FM4-64) was detected between wild-type and sla2talin cells (data not shown). 

Phrase: "As in budding yeast"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0014181:Yeast, Budding [Fungus]
   819 E C1961113:Yeast.budding [Fungus]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1155616:budding [Cell Function]
   737 E C2700462:Bud [Plant]
   737 E C2945744:bud [Anatomical Structure]

Phrase: "(Wesp et al.,"

Phrase: "1997"

Phrase: "; Yang et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "no obvious difference in bulk lipid endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "("

Phrase: "by up-take"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]
   861   C1515187:Take [Health Care Activity]

Phrase: "of the lipophilic steryl dye FM4-64"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0294936:FM4-64 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   804   C0598631:lipophilic [Quantitative Concept]
   804   C1424293:FM4 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "detected between wild-type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C0445392:Wild [Intellectual Product]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: As shown by calcofluor staining (Fig. 2B), the only defect detected in this strain was that most cells grew from only one end. 

Phrase: "As"

Phrase: "shown by calcofluor staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737   C1547282:Show [Intellectual Product]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "the only defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "detected in this strain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0080194:Strain [Injury or Poisoning]
   770   C0442726:Detected [Finding]
   770   C0456178:strain [Intellectual Product]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1518614:Strain [Organism]
   770   C2987481:Strain [Mental Process]

Phrase: "was"

Phrase: "that"

Phrase: "most cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grew from only one end."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0444930:End [Spatial Concept]
   760   C1720467:Only [Intellectual Product]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.92: Like wild-type cells, sla2talin cells had actin cables running along the main axis of the cell and cortical actin patches at growing ends. 

Phrase: "Like wild-type cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0449475:type cell [Intellectual Product]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "actin cables"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1819347:actin cable [Cell Component]
   861   C0492124:cables [Medical Device]
   861   C1428446:CABLES [Gene or Genome]

Phrase: "running along the main axis of the cell"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   744   C0004457:Axis [Body Part, Organ, or Organ Component]
   744   C0007634:Cell [Cell]
   744   C0035953:Running [Daily or Recreational Activity]
   744   C0205225:Main [Qualitative Concept]
   744   C0999597:Axis [Mammal]
   744   C1269647:Cell [Cell]
   744   C1522496:Axis [Spatial Concept]
   744   C1542147:Main [Qualitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2346414:Running [Finding]
   711 E C0600140:run [Finding]
   711 E C1704688:Run [Functional Concept]

Phrase: "and"

Phrase: "cortical actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "patches at growing ends."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0332461:Patch [Finding]
   770   C0444930:ends [Spatial Concept]
   770   C0445403:Patch [Biomedical or Dental Material]
   770   C0991556:Patch [Medical Device]
   770   C0994894:Patches [Medical Device]
   770   C1305400:Patch [Medical Device]
   770   C1533128:Patch [Biomedical or Dental Material]
   770   C1706366:{Patch} [Quantitative Concept]
   770   C1707974:Patch [Biomedical or Dental Material]
   737 E C2746065:End [Temporal Concept]
Processing 00000000.tx.93: Unlike the wild-type population, where only 15% of cells were in a pre-NETO state and showed monopolar actin, 78% of sla2talin cells had a monopolar distribution of cortical actin patches (Fig. 2A,B). 

Phrase: "Unlike the wild-type population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "where only 15% of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were in a pre-NETO state"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0332152:Pre [Temporal Concept]
   753   C0740175:Pre [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C1657233:NETO [Cell Function]
   753   C2257086:PRE [Genetic Function]
   753   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "monopolar actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "78% of sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "a monopolar distribution of cortical actin patches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
   732   C0205413:Patchy distribution [Qualitative Concept]

Phrase: "(Fig. 2A,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.94: The growth pattern of sla2talin cells was further analysed by time-lapse phase-contrast microscopy. 

Phrase: "The growth pattern of sla2talin cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1623229:cell growth pattern [Cell Function]
           growth pattern
   790   C1156245:Growth pattern [Finding]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analysed by time-lapse phase-contrast microscopy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   778   C0444701:Phase contrast [Laboratory Procedure]
   748   C0026018:Microscopy [Laboratory Procedure]
   748   C0040223:Time [Temporal Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C1979874:Contrast [Qualitative Concept]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.95: In wild-type cells after fission, both daughter cells activate growth from the old end (growing in the previous cycle). 

Phrase: "In wild-type cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0449475:type cell [Intellectual Product]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "after fission,"

Phrase: "both daughter cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007634:Cells [Cell]
   861   C0011011:Daughter [Family Group]
   861   C1610715:Daughter [Intellectual Product]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "growth from the old end ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "growing in the previous cycle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205156:Previous [Temporal Concept]
   760   C1511572:Cycle [Temporal Concept]
   760   C1552607:previous [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.96: In contrast, in 53% of sla2talin cells one daughter cell grew from the old end and one from the new end (Fig. 2D). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in 53%"

Phrase: "of sla2talin cells one daughter cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011011:Daughter [Family Group]
   804   C1610715:Daughter [Intellectual Product]

Phrase: "grew from the old end"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0444930:End [Spatial Concept]
   760   C0580836:Old [Temporal Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "one from the new end (Fig. 2D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.98: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.99: End4/Sla2 talin-like domain is required for actin organization at new growth zones. 

Phrase: "End4/Sla2 talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for actin organization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0029237:Organisation [Physiologic Function]
   770   C0029246:Organization [Organization]
   770   C0220885:organization [Qualitative Concept]
   770   C1300196:Organization [Functional Concept]
   770   C1514873:Required [Functional Concept]
   770   C1522486:Organization [Professional or Occupational Group]

Phrase: "at new growth zones."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1710706:Zone [Spatial Concept]
   743 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0027651:New growth [Neoplastic Process]
Processing 00000000.tx.100: (A) Schematic organization of End4/Sla2 mutant proteins generated in these study and percentage of cells with monopolar growth in each strain. 

Phrase: "(A) Schematic organization of End4/Sla2 mutant proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0029237:Organisation [Physiologic Function]
   744   C0029246:Organization [Organization]
   744   C0220885:organization [Qualitative Concept]
   744   C1300196:Organization [Functional Concept]
   744   C1522486:Organization [Professional or Occupational Group]

Phrase: "generated in these study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "with monopolar growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1752489:monopolar growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "in each strain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
Processing 00000000.tx.101: (B) Wild-type (left) and sla2talin (right) cells were stained with calcofluor (upper panel) and for actin (lower panel). 

Phrase: "(B) Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "sla2talin"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with calcofluor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and for actin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1515981:And [Idea or Concept]
   718 E C0439681:Actinic [Qualitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.102: (C) Western blot analysis of total extracts from wild-type, Sla2-GFP and Sla2talin-GFP strains with -GFP (top) and -tubulin (bottom) antibody. 

Phrase: "(C) Western blot analysis of total extracts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "from wild-type, Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Sla2talin-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "strains with -GFP ("
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   790   C0080194:Strain [Injury or Poisoning]
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C0456178:strain [Intellectual Product]
   790   C1518614:Strain [Organism]
   790   C2987481:Strain [Mental Process]
   734 E C0180860:Filter [Manufactured Object]
   734 E C0581406:Filter [Medical Device]
   734 E C1522664:Filter [Intellectual Product]
   734 E C1704449:Filter [Conceptual Entity]
   734 E C1704684:Filter [Medical Device]
   734 E C1875155:FILTER [Medical Device]
   706 E C0442694:Straining [Physiologic Function]

Phrase: "top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.103: (D) Patterns of growth of sla2talin, tea1 and sla2talin tea1 cells after division.  

Phrase: "("

Phrase: "D)"

Phrase: "Patterns of growth of sla2talin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1156245:growth patterns [Finding]
   781 E C1623229:growth pattern [Cell Function]
   760   C0449774:Patterns [Spatial Concept]

Phrase: "tea1"

Phrase: "and"

Phrase: "sla2talin tea1 cells after division."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0007590:cells division [Cell Function]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.104: Deletion of the talin-like domain did not affect End4/Sla2 protein levels (Fig. 2C). 

Phrase: "Deletion of the talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "End4/Sla2 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.105: Moreover, sla2talin cells showed no obvious defect in bulk lipid endocytosis, using the FM4-64 uptake assay (data not shown). 

Phrase: "Moreover,"

Phrase: "sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no obvious defect in bulk lipid endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the FM4-64 uptake assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: Thus as in S. cerevisiae, the C-terminal talin-like domain is dispensable for most End4/Sla2 functions. 

Phrase: "Thus"

Phrase: "as in S. cerevisiae,"

Phrase: "the C-terminal talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "dispensable for most End4/Sla2 functions."
Processing 00000000.tx.107: However, in S. pombe the End4/Sla2 talin-like domain is required for activation of growth at the new end, and possibly mediates recruitment of actin to the new end. 

Phrase: "However,"

Phrase: "in S. pombe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178453:S pombe [Fungus]

Phrase: "the End4/Sla2 talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for activation of growth"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C2249824:activation of growth [Organism Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1514873:Required [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1879547:Activation [Activity]
   760   C2911660:Growth [Activity]

Phrase: "at the new end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "recruitment of actin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2949735:Recruitment [Activity]

Phrase: "to the new end."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.108: Further support for this was obtained by mutating arginine 1083, which abolishes binding of the isolated I/LWEQ-module to F-actin (McCann and Craig, 1999). 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support for this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0183683:Support [Medical Device]
   790   C1521721:Support [Conceptual Entity]

Phrase: "was"

Phrase: "obtained by mutating arginine 1083,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1301820:Obtained [Functional Concept]
   726   C1513776:Mutate [Genetic Function]
   726 E C1706701:Obtain [Activity]

Phrase: "which"

Phrase: "abolishes"

Phrase: "binding of the isolated I/LWEQ-module"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to F-actin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "(McCann"

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.109: Cells bearing this point mutation (Sla2R1083G) in End4/Sla2 showed NETO defects; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "this point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "(Sla2R1083G"

Phrase: ")"

Phrase: "in End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "NETO defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.110: 62% of cells grew in a monopolar fashion with a monopolar actin pattern (Fig. 2A). 

Phrase: "62% of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grew in a monopolar fashion"

Phrase: "with a monopolar actin pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.111: To test if the talin-like domain plays an essential role in the switch to bipolar growth, we checked whether it was possible to promote NETO in sla2talin cells by making actin monomers available in the cell. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in the switch"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "to bipolar growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1326221:bipolar growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "we"

Phrase: "checked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Checked [Activity]

Phrase: "whether"

Phrase: "it"

Phrase: "was"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NETO in sla2talin cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1657233:NETO [Cell Function]

Phrase: "by making actin monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "available in the cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]
Processing 00000000.tx.112: A pool of free actin monomers could be generated with a pulse of latranculin A (latA) (Rupes et al., 1999). 

Phrase: "A pool of free actin monomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "generated with a pulse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0232117:PULSE [Clinical Attribute]
   770   C0391850:Pulse [Physiologic Function]
   770   C1947910:Pulse [Phenomenon or Process]
   770   C3146294:Generated [Activity]

Phrase: "of latranculin A (latA) (Rupes et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.113: Cdc10-129 and cdc10-129 sla2talin cells were blocked for 2 hours at restrictive temperature (36C). 

Phrase: "Cdc10-129"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539749:CDC10 [Gene or Genome]

Phrase: "and"

Phrase: "cdc10-129 sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked for 2 hours"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0439227:hours [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C0564385:/hour [Quantitative Concept]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "at restrictive temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "(36C"

Phrase: ")."
Processing 00000000.tx.114: After the block, cells of both genotypes showed a monopolar actin distribution: 89% in cdc10-129 and 98% in cdc10-129 sla2talin cells (Fig. 3A). 

Phrase: "After the block,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "cells of both genotypes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a monopolar actin distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: ":"

Phrase: "89% in cdc10-129"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539749:CDC10 [Gene or Genome]

Phrase: "and"

Phrase: "98% in cdc10-129 sla2talin cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C1539749:CDC10 [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.115: Cells were than treated for 6 minutes with 40 M latA, which completely disrupted actin localization (Fig. 3B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were than"

Phrase: "treated for 6 minutes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   770   C2347166:Minute [Quantitative Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 40 M latA,"

Phrase: "which completely disrupted actin localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.116: After washing out the drug, actin localization was followed for up to 120 minutes at 36C. 

Phrase: "After"

Phrase: "washing out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022100:washing out [Therapeutic or Preventive Procedure]
   861   C0441648:Washing [Activity]

Phrase: "the drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "actin localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "followed for"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0332283:followed [Temporal Concept]
   799 E C1719822:Follow [Intellectual Product]

Phrase: "up to 120 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at 36C."
Processing 00000000.tx.117: Within 1 hour most cdc10-129 cells showed a bipolar actin distribution, whereas most cells bearing the talin deletion in End4/Sla2 had monopolar actin patches. 

Phrase: "Within 1 hour most cdc10-129 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a bipolar actin distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "whereas"

Phrase: "most cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the talin deletion in End4/Sla2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "had"

Phrase: "monopolar actin patches."
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   884   C1166660:actin patch [Cell Component]
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]
Processing 00000000.tx.118: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.119: 3A, 2 hours after wash out of the drug, 76% of cdc10-129 cells showed a bipolar actin distribution compared to 22% of cdc10-129 sla2talin cells. 

Phrase: "3A,"

Phrase: "2 hours after wash out of the drug,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1292425:2 Hours [Temporal Concept]
   744   C0439227:hours [Temporal Concept]
   711 E C0564385:/hour [Quantitative Concept]

Phrase: "76% of cdc10-129 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1539749:CDC10 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a bipolar actin distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "compared to 22% of cdc10-129 sla2talin cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0007634:Cells [Cell]
   744   C1539749:CDC10 [Gene or Genome]
   744   C1707455:Compared [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.120: These results suggest that End4/Sla2 talin-like domain plays an essential role in the switch from monopolar to bipolar growth and in the organization of cortical actin patches at the new end. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that End4/Sla2 talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in the switch"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "from monopolar"

Phrase: "to bipolar growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1326221:bipolar growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and in the organization of cortical actin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001613:Cortical [Body Part, Organ, or Organ Component]
   748   C0007776:Cortical [Body Part, Organ, or Organ Component]
   748   C0022655:Cortical [Body Part, Organ, or Organ Component]
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
   748   C0220885:organization [Qualitative Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1522486:Organization [Professional or Occupational Group]

Phrase: "patches at the new end."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0205314:New [Temporal Concept]
   760   C0332461:Patch [Finding]
   760   C0444930:End [Spatial Concept]
   760   C0445403:Patch [Biomedical or Dental Material]
   760   C0991556:Patch [Medical Device]
   760   C0994894:Patches [Medical Device]
   760   C1305400:Patch [Medical Device]
   760   C1533128:Patch [Biomedical or Dental Material]
   760   C1706366:{Patch} [Quantitative Concept]
   760   C1707974:Patch [Biomedical or Dental Material]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.121: View larger version (44K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.123: End4/Sla2 talin-like domain is required for establishment of a new growth zone. 

Phrase: "End4/Sla2 talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for establishment of a new growth zone."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0027651:New growth [Neoplastic Process]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205314:New [Temporal Concept]
   744   C0220844:growth [Physiologic Function]
   744   C1514873:Required [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1710706:Zone [Spatial Concept]
   744   C2911660:Growth [Activity]
Processing 00000000.tx.124: (A) Schematic representation of latA pulse experiment (top) and scoring (bottom) of cells with monopolar actin distribution before the treatment (grey) and 2 hours after wash out (black). 

Phrase: "(A) Schematic representation of latA pulse experiment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0232117:PULSE [Clinical Attribute]
   744   C0391850:Pulse [Physiologic Function]
   744   C0681814:Experiment [Research Activity]
   744   C1514861:Representation [Conceptual Entity]
   744   C1706386:Experiment [Conceptual Entity]
   744   C1882932:Representation [Activity]
   744   C1947910:Pulse [Phenomenon or Process]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "scoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449820:scoring [Quantitative Concept]
  1000   C1552081:scoring [Idea or Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with monopolar actin distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "before the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "(grey"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "2 hours after wash out"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292425:2 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.125: (B) Cells before (top), during (middle) and 2 hours after latA treatment (bottom): cdc10-129 (left) cdc10-129 sla2talin (right). 

Phrase: "(B) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "before"

Phrase: "(top),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "during"

Phrase: "(middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "2 hours after latA treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C1292425:2 Hours [Temporal Concept]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0439227:hours [Temporal Concept]
   753   C0740116:+2 [Quantitative Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C2827735:2+ [Quantitative Concept]
   753   C2981700:2+ [Classification]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "cdc10-129"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539749:CDC10 [Gene or Genome]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "cdc10-129 sla2talin"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.126: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.127: End4/Sla2 is enriched at sites of actin accumulation We next determined the localization of End4/Sla2 in the cell throughout the cell cycle by using a C-terminal Sla2-GFP fusion expressed from the sla2 endogenous promoter. 

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "enriched at sites of actin accumulation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C2945843:Site of [Qualitative Concept]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205145:Sites [Spatial Concept]
   753   C0359583:enriched [Food]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "the localization of End4/Sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "throughout the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a C-terminal Sla2-GFP fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "expressed from the sla2 endogenous promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205227:Endogenous [Functional Concept]
   753   C1424907:SLA2 [Gene or Genome]
Processing 00000000.tx.128: The GFP fusion protein is functional, as Sla2-GFP fully rescued the defects observed in sla2 cells. 

Phrase: "The GFP fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "functional,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "Sla2-GFP fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "rescued"

Phrase: "the defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243067:defects [Functional Concept]
   966 E C1457869:Defect [Functional Concept]
   966 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "observed in sla2 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1424907:SLA2 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: During interphase, Sla2-GFP accumulated in cortical dots at both cell ends (Fig. 4A) at the site of cell growth and actin patch accumulation. 

Phrase: "During interphase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021798:Interphase [Cell Function]

Phrase: "Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "accumulated in cortical dots"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   770   C1720485:Dots [Finding]
   737 E C0872145:DOT [Therapeutic or Preventive Procedure]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: "at both cell ends"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "at the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "actin patch accumulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1166660:actin patch [Cell Component]
Processing 00000000.tx.130: Evaluation of individual Sla2-GFP patches revealed a lifetime of 110-150 seconds. 

Phrase: "Evaluation of individual Sla2-GFP patches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a lifetime of 110-150 seconds."
Processing 00000000.tx.131: During early mitosis, Sla2-GFP dots form a ring in the middle of the cell, overlying the nucleus, which persists until the end of mitosis (Fig. 4A). 

Phrase: "During early mitosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026255:Mitosis [Cell Function]
   789 E C1513354:Mitotic [Qualitative Concept]

Phrase: "Sla2-GFP dots"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1720485:Dots [Finding]
   793 E C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a ring in the middle of the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0521164:Ring [Spatial Concept]
   744   C1260969:Ring [Medical Device]
   744   C1705184:Ring [Medical Device]
   739   C1818663:medial ring [Cell Component]

Phrase: "overlying"

Phrase: "the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "which"

Phrase: "persists until the end of mitosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026255:Mitosis [Cell Function]
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.132: Upon cell division, Sla2-GFP localization was re-established at the old end. 

Phrase: "Upon cell division,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007590:Cell division [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1293097:Division [Therapeutic or Preventive Procedure]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2919030:Division [Organization]
   861   C2919031:Division [Activity]

Phrase: "Sla2-GFP localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "re-established at the old end."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0443211:Established [Qualitative Concept]
   753   C0444930:End [Spatial Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C2746065:End [Temporal Concept]
   753   C2986904:RE [Idea or Concept]
Processing 00000000.tx.133: Time-lapse movies (data not shown) of single cells expressing Sla2-GFP showed that after cell division only a few dots were left at the new end. 

Phrase: "Time-lapse movies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681495:movies [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "of single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "after"

Phrase: "cell division only"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007590:Cell division [Cell Function]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1293097:Division [Therapeutic or Preventive Procedure]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2919030:Division [Organization]
   827   C2919031:Division [Activity]

Phrase: "a few dots"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1720485:Dots [Finding]
   827 E C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "left at the new end."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0205091:Left [Spatial Concept]
   760   C0205314:New [Temporal Concept]
   760   C0444930:End [Spatial Concept]
   760   C1552822:left [Functional Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.134: Shortly after division, Sla2-GFP quickly accumulated again at cell ends, giving rise to the bipolar interphase pattern (data not shown). 

Phrase: "Shortly"

Phrase: "after"

Phrase: "division,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293097:Division [Therapeutic or Preventive Procedure]
  1000   C2919030:Division [Organization]
  1000   C2919031:Division [Activity]

Phrase: "Sla2-GFP quickly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "accumulated"

Phrase: "again at cell ends,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C1656978:cell end [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0444930:ends [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C2746065:End [Temporal Concept]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the bipolar interphase pattern"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: To determine whether End4/Sla2 accumulates only at growing cell ends, we examined the pattern of Sla2-GFP localization in the temperature-sensitive cell cycle mutants cdc10-129 and cdc25-22 (Mitchison and Nurse, 1985), which block before and after activation of bipolar growth, respectively. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "accumulates"

Phrase: "only at growing cell ends,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   851   C3159038:growing cell end [Cell Component]
   790   C1656978:cell end [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C0444930:ends [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1720467:Only [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]
   726 E C2746065:End [Temporal Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the pattern of Sla2-GFP localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "in the temperature-sensitive cell cycle mutants cdc10-129"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   851   C0597561:temperature sensitive mutant [Cell or Molecular Dysfunction]
   818   C0007586:Cell Cycle [Cell Function]
   818   C1155839:Cell Cycle [Cell Function]
   795   C0005903:temperature [Organism Attribute]
   795   C0007634:Cell [Cell]
   795   C0039476:*Temperature [Quantitative Concept]
   795   C0332324:Sensitive [Functional Concept]
   795   C0596988:mutants [Cell or Molecular Dysfunction]
   795   C1269647:Cell [Cell]
   795   C1511572:Cycle [Temporal Concept]
   795   C1539749:CDC10 [Gene or Genome]
   795   C1550474:sensitive [Idea or Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cdc25-22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538850:CDC25 [Gene or Genome]

Phrase: "(Mitchison"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1985"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "and after activation of bipolar growth,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C2249824:activation of growth [Organism Function]
   790   C1326221:bipolar growth [Cell Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0443156:Bipolar [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1879547:Activation [Activity]
   753   C2911660:Growth [Activity]

Phrase: "respectively."
Processing 00000000.tx.136: When shifted to the restrictive temperature, cdc10-129 cells blocked, before NETO, with monopolar actin and monopolar Sla2-GFP distribution (Fig. 4D). 

Phrase: "When"

Phrase: "shifted to the restrictive temperature,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0333051:shifted [Functional Concept]
   726 E C2347509:Shift [Phenomenon or Process]

Phrase: "cdc10-129 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: ","

Phrase: "before"

Phrase: "NETO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657233:NETO [Cell Function]

Phrase: "with monopolar actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "monopolar Sla2-GFP distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.137: Conversely, cdc25-22 cells, at restrictive temperature, blocked entry into mitosis and accumulated as long rod-shaped cells with bipolar actin and bipolar Sla2-GFP (data not shown). 

Phrase: "Conversely,"

Phrase: "cdc25-22 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "at restrictive temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "blocked entry into mitosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705654:Entry [Intellectual Product]

Phrase: "and"

Phrase: "accumulated as long rod-shaped cells"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   783   C0162657:cells shaped [Organism Attribute]
   783   C0206427:cells rod [Cell]
           Rod
   773   C1947942:Rod Shape [Spatial Concept]
           Rod
   753   C0007634:Cells [Cell]
   753   C0205166:Long [Qualitative Concept]
   753   C0332479:shaped [Spatial Concept]
   753   C0522512:shaped [Spatial Concept]
   753   C1552915:rod [Quantitative Concept]
   753   C1705186:Rod [Medical Device]
   753   C1706317:Long [Qualitative Concept]
   753   C2347970:rod [Quantitative Concept]
   753   C2347971:rod [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0348078:shape [Qualitative Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with bipolar actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "bipolar Sla2-GFP (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: We conclude that End4/Sla2 has a distribution that mirrors that of the cortical actin patches, accumulating at actively growing tips during interphase and re-localizing to a central ring prior to mitosis. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "has"

Phrase: "a distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "that"

Phrase: "mirrors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181868:Mirror [Manufactured Object]
  1000   C1706183:Mirror [Manufactured Object]

Phrase: "that of the cortical actin patches,"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   803   C1166660:actin cortical patch [Cell Component]
           actin patch
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0994894:Patches [Medical Device]
   719 E C0332461:Patch [Finding]
   719 E C0445403:Patch [Biomedical or Dental Material]
   719 E C0991556:Patch [Medical Device]
   719 E C1305400:Patch [Medical Device]
   719 E C1533128:Patch [Biomedical or Dental Material]
   719 E C1706366:{Patch} [Quantitative Concept]
   719 E C1707974:Patch [Biomedical or Dental Material]

Phrase: "accumulating at actively growing tips"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0339897:TIPS [Therapeutic or Preventive Procedure]
   726 E C1710425:Tip [Medical Device]
   726 E C3282898:Tip [Qualitative Concept]

Phrase: "during interphase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021798:Interphase [Cell Function]

Phrase: "and"

Phrase: "re-localizing to a central ring"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205099:Central [Spatial Concept]
   753   C0392752:localizing [Spatial Concept]
   753   C0521164:Ring [Spatial Concept]
   753   C1260969:Ring [Medical Device]
   753   C1705184:Ring [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   753   C2986904:RE [Idea or Concept]

Phrase: "prior to mitosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026255:Mitosis [Cell Function]
   928 E C1513354:Mitotic [Qualitative Concept]
Processing 00000000.tx.139: However, co-staining of Sla2-GFP and actin showed only a partial colocalization of End4/Sla2 dots and actin patches (Fig. 4D,E). 

Phrase: "However,"

Phrase: "co-staining of Sla2-GFP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1424907:SLA2 [Gene or Genome]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a partial colocalization of End4/Sla2 dots"

Phrase: "and"

Phrase: "actin patches"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   983   C1166660:actin patch [Cell Component]
   861   C0994894:Patches [Medical Device]
   827 E C0332461:Patch [Finding]
   827 E C0445403:Patch [Biomedical or Dental Material]
   827 E C0991556:Patch [Medical Device]
   827 E C1305400:Patch [Medical Device]
   827 E C1533128:Patch [Biomedical or Dental Material]
   827 E C1706366:{Patch} [Quantitative Concept]
   827 E C1707974:Patch [Biomedical or Dental Material]
   777 E C0205413:Patchy [Qualitative Concept]

Phrase: "(Fig. 4D,E"

Phrase: ")."
Processing 00000000.tx.140: View larger version (88K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(88K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.141: 4. 

Phrase: "4."
Processing 00000000.tx.142: End4/Sla2 localization in vivo. 

Phrase: "End4/Sla2 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.143: (A) Sla2-GFP accumulation (green) at cell ends during interphase (top) and in a medial ring over the nucleus (middle), which persists until the end of mitosis (bottom). 

Phrase: "(A) Sla2-GFP accumulation"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "at cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "ends during interphase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021798:Interphase [Cell Function]
   790   C0444930:End [Spatial Concept]
   790   C2746065:End [Temporal Concept]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and in a medial ring"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1818663:medial ring [Cell Component]
   760   C0205098:Medial [Spatial Concept]
   760   C0521164:Ring [Spatial Concept]
   760   C1260969:Ring [Medical Device]
   760   C1515981:And [Idea or Concept]
   760   C1705184:Ring [Medical Device]

Phrase: "over the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "persists until the end of mitosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026255:Mitosis [Cell Function]
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.144: The nucleus is stained with DAPI (blue). 

Phrase: "The nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "is"

Phrase: "stained with DAPI (blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.145: (B) Central accumulation of Sla2-GFP is unaffected in tea1 cells (arrow). 

Phrase: "(B) Central accumulation of Sla2-GFP"

Phrase: "is"

Phrase: "unaffected in tea1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.146: Sla2-GFP is enriched only at the growing end in tea1 and (C) in tea1(200) cells. 

Phrase: "Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "enriched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:enriched [Food]

Phrase: "only at the growing end"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C0444930:End [Spatial Concept]
   760   C1720467:Only [Intellectual Product]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "in tea1"

Phrase: "and ("

Phrase: "C) in tea1"

Phrase: "(200"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.147: (D) Accumulation of Sla2-GFP (bottom) and actin (top) at the growing end in cdc10-129 cells. 

Phrase: "("

Phrase: "D)"

Phrase: "Accumulation of Sla2-GFP (bottom"

Phrase: ")"

Phrase: "and"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(top) at the growing end"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704458:Top [Spatial Concept]

Phrase: "in cdc10-129 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.148: (E) Staining of Sla2-GFP-expressing cells with -actin and (F) -Tea1 antibody. 

Phrase: "(E) Staining of Sla2-GFP-expressing cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "with -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and ("

Phrase: "F) -Tea1 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0370187:f Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.149: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.150: The proper location of new growth zones relies on the polarity marker Tea1, which defines cell geometry by marking sites of cell growth (Mata and Nurse, 1997). 

Phrase: "The proper location of new growth zones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]

Phrase: "relies on the polarity marker Tea1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005516:Marker [Clinical Attribute]
   753   C0596963:Polarity [Quantitative Concept]

Phrase: "which"

Phrase: "defines"

Phrase: "cell geometry by marking sites of cell growth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449829:Geometry [Spatial Concept]

Phrase: "(Mata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.151: Double labelling of Sla2-GFP-expressing cells with GFP and Tea1 antibodies showed some colocalization of the two proteins at cell tips (Fig. 4F). 

Phrase: "Double labelling of Sla2-GFP-expressing cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0205173:Double [Functional Concept]
   748   C1167624:Labeling [Mental Process]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]
   714 E C0181496:Label [Manufactured Object]

Phrase: "with GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Tea1 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "some colocalization of the two proteins"

Phrase: "at cell tips (Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450379:4f [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: As End4/Sla2 also associates closely with the actin cytoskeleton and the growth machinery, we tested whether its localization depends on Tea1. 

Phrase: "As End4/Sla2 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424907:SLA2 [Gene or Genome]

Phrase: "associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "closely with the actin cytoskeleton"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0025979:Actin Cytoskeleton [Cell Component]
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0010853:Cytoskeleton [Cell Component]
   760   C1748451:Cytoskeleton [Cell Component]

Phrase: "and"

Phrase: "the growth machinery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "its localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "depends on Tea1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]
Processing 00000000.tx.153: The central accumulation of Sla2-GFP at the ring was unaffected in tea1 cells, whereas the end localization of Sla2-GFP was abnormal. 

Phrase: "The central accumulation of Sla2-GFP"

Phrase: "at the ring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521164:Ring [Spatial Concept]
  1000   C1260969:Ring [Medical Device]
  1000   C1705184:Ring [Medical Device]

Phrase: "was"

Phrase: "unaffected in tea1 cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "whereas"

Phrase: "the end localization of Sla2-GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "abnormal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205161:Abnormal [Qualitative Concept]
  1000   C2347472:% Abnormal [Quantitative Concept]
  1000   C2699333:ABNORMAL [Intellectual Product]
Processing 00000000.tx.154: Instead of the normal bipolar localization, most cells showed monopolar Sla2-GFP accumulation at the growing end (Fig. 4B) throughout the cell cycle, suggesting a role for Tea1 in proper End4/Sla2 localization. 

Phrase: "Instead of the normal bipolar localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "most cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "monopolar Sla2-GFP accumulation at the growing end (Fig. 4B"

Phrase: ")"

Phrase: "throughout the cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for Tea1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in proper End4/Sla2 localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]
Processing 00000000.tx.155: However, because Tea1 influences microtubular organization, the aberrant pattern of Sla2-GFP localization could also be an indirect consequence of the defective microtubular array observed in tea1 cells. 

Phrase: "However,"

Phrase: "because"

Phrase: "Tea1"

Phrase: "influences"

Phrase: "microtubular organization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "the aberrant pattern of Sla2-GFP localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "an indirect consequence of the defective microtubular array"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "observed in tea1 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: To distinguish between these two possibilities, we examined the pattern of Sla2-GFP localization in tea1(200) cells, which show a wild-type array of microtubules but fail to accumulate the truncated version of Tea1 at cell ends (Behrens and Nurse, 2002). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between these two possibilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the pattern of Sla2-GFP localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "in tea1"

Phrase: "(200"

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a wild-type array of microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510941:Array [Spatial Concept]

Phrase: "but"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate"

Phrase: "the truncated version of Tea1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333052:Version [Functional Concept]
   760   C2607870:Version [Spatial Concept]

Phrase: "at cell ends"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "(Behrens"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.157: tea1(200) cells showed monopolar Sla2-GFP accumulation which occurred only at growing ends, even though microtubules were normal in these cells (Fig. 4C). 

Phrase: "tea1"

Phrase: "(200"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "monopolar Sla2-GFP accumulation"

Phrase: "which"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "only at growing ends,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0444930:ends [Spatial Concept]
   770   C1720467:Only [Intellectual Product]
   737 E C2746065:End [Temporal Concept]

Phrase: "even"

Phrase: "though"

Phrase: "microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "were"

Phrase: "normal in these cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0007634:Normal cell [Cell]
   802   C1268443:Normal cell [Cell]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.158: Hence, Tea1 is necessary to recruit End4/Sla2 to the new end where growth has not previously occurred, independently of its effect on microtubules. 

Phrase: "Hence,"

Phrase: "Tea1"

Phrase: "is"

Phrase: "necessary to"

Phrase: "recruit"

Phrase: "End4/Sla2 to the new end where growth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1424907:SLA2 [Gene or Genome]

Phrase: "has"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "independently of its effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]
Processing 00000000.tx.159: To further test if the accumulation of End4/Sla2 at cell ends required the microtubule or actin cytoskeletons, we performed a cdc10 block and release experiment in the presence of 25 g/ml MBC, which depolymerizes microtubules, or 40 M latA, which sequesters actin monomers leading to complete disassembly of the actin cytoskeleton. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "the accumulation of End4/Sla2"

Phrase: "at cell ends"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "the microtubule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Micro-tubule [Cell Component]

Phrase: "or"

Phrase: "actin cytoskeletons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0025979:Cytoskeletons, Actin [Cell Component]
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a cdc10 block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "release experiment in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "of 25 g/ml MBC,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   845   C0066233:methyl carbamate [Organic Chemical]
   795   C0005050:benzimidazole [Organic Chemical]
   795   C0006948:Carbamate [Organic Chemical]
   795   C0053183:benzimidazole [Organic Chemical]

Phrase: "which"

Phrase: "depolymerizes"

Phrase: "microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "or"

Phrase: "40 M latA,"

Phrase: "which"

Phrase: "sequesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "actin monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "disassembly of the actin cytoskeleton."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1707798:Disassembly [Activity]
   760   C1880352:DISASSEMBLY [Phenomenon or Process]
Processing 00000000.tx.160: Cells were blocked at the restrictive temperature of 36C for 3 hours to allow most cells to accumulate in G1 with monopolar Sla2-GFP. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked at the restrictive temperature of 36C"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0005903:temperature [Organism Attribute]
   748   C0028778:Blocked [Pathologic Function]
   748   C0039476:*Temperature [Quantitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "for 3 hours to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1442460:3 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "most cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "accumulate in G1"

Phrase: "with monopolar Sla2-GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.161: Cells were then released to the permissive temperature in MBC or latA to allow cells to proceed through the cell cycle in the absence of microtubules or F-actin structures, respectively. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "released to the permissive temperature"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in MBC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   902   C0066233:methyl carbamate [Organic Chemical]
   812   C0005050:benzimidazole [Organic Chemical]
   812   C0006948:Carbamate [Organic Chemical]
   812   C0053183:benzimidazole [Organic Chemical]

Phrase: "or"

Phrase: "latA to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "proceed through the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007586:Cell Cycle [Cell Function]
   806   C1155839:Cell Cycle [Cell Function]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "or"

Phrase: "F-actin structures,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678594:structures [Spatial Concept]
   734   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1622186:F-actin [Cell Component]

Phrase: "respectively."
Processing 00000000.tx.162: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.163: 5, neither the MBC nor the latA treatment impaired Sla2-GFP accumulation at the new end. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "neither"

Phrase: "the MBC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   902   C0066233:methyl carbamate [Organic Chemical]
   812   C0005050:benzimidazole [Organic Chemical]
   812   C0006948:Carbamate [Organic Chemical]
   812   C0053183:benzimidazole [Organic Chemical]

Phrase: "nor"

Phrase: "the latA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "Sla2-GFP accumulation at the new end."
Processing 00000000.tx.164: Bipolar accumulation of Sla2-GFP was also observed when cells were treated with both MBC and latA together, excluding the possibility of a redundant dependence between the two systems (Fig. 5). 

Phrase: "Bipolar accumulation of Sla2-GFP"

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with both MBC"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   853   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C0066233:methyl carbamate [Organic Chemical]
   748   C0005050:benzimidazole [Organic Chemical]
   748   C0006948:Carbamate [Organic Chemical]
   748   C0053183:benzimidazole [Organic Chemical]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "latA together,"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the possibility of a redundant dependence"

Phrase: "between the two systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: Taken together these observations suggest that End4/Sla2 end localization does not directly require the actin and microtubular cytoskeletons. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that End4/Sla2 end localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "does"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "require"

Phrase: "the actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "microtubular cytoskeletons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.166: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.168: Localization of Sla2-GFP is independent of the actin and microtubule cytoskeletons. 

Phrase: "Localization of Sla2-GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "is independent of the actin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332291:Independent of [Functional Concept]
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]

Phrase: "and"

Phrase: "microtubule cytoskeletons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1166781:Microtubule cytoskeleton [Cell Component]
   861   C0010853:Cytoskeletons [Cell Component]
   827 E C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.169: (A) cdc10-129 cells expressing Sla2-GFP were grown at 25C and then transferred to 36C for 3 hours (left). 

Phrase: "(A) cdc10-129 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Sla2-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "grown at 25C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to 36C"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "for 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.170: After addition of DMSO or 40 M latA or 25 g/ml MBC, or 25 g/ml MBC plus 40 M latA (indicated by an arrow in the scheme) respectively, cells were released to permissive temperature (25C) for an hour in the presence of the drug and then analysed for Sla2-GFP localization (right panels). 

Phrase: "After addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "40 M latA"

Phrase: "or"

Phrase: "25 g/ml MBC,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   845   C0066233:methyl carbamate [Organic Chemical]
   795   C0005050:benzimidazole [Organic Chemical]
   795   C0006948:Carbamate [Organic Chemical]
   795   C0053183:benzimidazole [Organic Chemical]

Phrase: "or"

Phrase: "25 g/ml MBC plus 40 M latA ("
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0456715:g m [Quantitative Concept]
   827   C0065839:Methyl-2-benzimidazolecarbamate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   816   C0066233:methyl carbamate [Organic Chemical]
   799   C1300565:g/mL [Quantitative Concept]
   787   C0005050:benzimidazole [Organic Chemical]
   787   C0006948:Carbamate [Organic Chemical]
   787   C0053183:benzimidazole [Organic Chemical]
   787   C0332287:Plus [Qualitative Concept]
   787   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   787   C0439267:g% [Quantitative Concept]
   787   C0439509:/40 [Temporal Concept]
   787   C0439526:/mL [Quantitative Concept]
   787   C0441923:M+ [Intellectual Product]

Phrase: "indicated by an arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]

Phrase: "in the scheme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: ")"

Phrase: "respectively,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "released to permissive temperature"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(25C"

Phrase: ")"

Phrase: "for an hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analysed for Sla2-GFP localization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0475264:Localisation [Functional Concept]
   760   C1424907:SLA2 [Gene or Genome]
   760   C1744691:localisation [Biologic Function]

Phrase: "(right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.171: (B) Quantification of cells with bipolar actin distribution at 36C (black bar) and 30 minutes after shift down to 25C (white and grey bars) in the presence of the different drugs. 

Phrase: "(B) Quantification of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "with bipolar actin distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "at 36C"

Phrase: "(black bar)"

Phrase: "and"

Phrase: "30 minutes after shift"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0456693:/30 minutes [Temporal Concept]
   833   C1442458:30 Minutes [Temporal Concept]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]

Phrase: "down"

Phrase: "to 25C"

Phrase: "(white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "and"

Phrase: "grey bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the different drugs."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.172: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.173: End4/Sla2 localization depends on vesicular traffic In fission yeast, membrane trafficking is required for proper actin ring dynamics and affects its localization (Pardo and Nurse, 2003). 

Phrase: "End4/Sla2 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "depends on vesicular traffic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205378:Vesicular [Qualitative Concept]
   770   C0725813:depend [Medical Device]

Phrase: "In fission yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "is"

Phrase: "required for proper actin ring dynamics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0521164:Ring [Spatial Concept]
   753   C1260969:Ring [Medical Device]
   753   C1514873:Required [Functional Concept]
   753   C1705184:Ring [Medical Device]

Phrase: "and"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "(Pardo"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.174: The presence of a ENTH domain, shown to be involved in membrane binding (Ford et al., 2001; Itoh et al., 2001) at the C terminus of End4/Sla2, and the tight association of End4/Sla2 with the cortical membrane after latA treatment, led us to investigate whether membrane trafficking is also involved in localizing End4/Sla2 at cell ends. 

Phrase: "The presence of a ENTH domain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in membrane binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0025255:Membrane [Tissue]
   770   C0243122:binding [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1314939:Involved [Functional Concept]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "(Ford et al.,"

Phrase: "2001"

Phrase: "; Itoh et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "at the C terminus"

Phrase: "of End4/Sla2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "and"

Phrase: "the tight association of End4/Sla2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with the cortical membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "after latA treatment,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   902   C0001758:After-Treatment [Health Care Activity]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C0231290:After [Temporal Concept]
   812   C0687676:After [Temporal Concept]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "is"

Phrase: "also"

Phrase: "involved in localizing End4/Sla2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392752:localizing [Spatial Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1424907:SLA2 [Gene or Genome]

Phrase: "at cell ends."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.175: Brefeldin A (BfA) blocks protein secretion by blocking vesicular transfer from the endoplasmic reticulum to the Golgi and therefore disrupting the Golgi apparatus. 

Phrase: "Brefeldin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(BfA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "protein secretion by blocking vesicular transfer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "from the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "to the Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "and"

Phrase: "therefore"

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the Golgi apparatus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]
Processing 00000000.tx.176: Treatment with BfA does not affect Tea1 localization (Mata and Nurse, 1997), but it caused Sla2-GFP to disappear completely from cell tips, becoming randomly distributed throughout the cell within 5 minutes (Fig. 6Ac), suggesting that End4/Sla2 accumulation at cell ends might be mediated by active vesicular trafficking. 

Phrase: "Treatment with BfA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Tea1 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "(Mata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "Sla2-GFP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "disappear"

Phrase: "completely from cell tips,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   816   C1656978:cell tip [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0205197:Completely [Qualitative Concept]
   770   C0339897:TIPS [Therapeutic or Preventive Procedure]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1710425:Tip [Medical Device]
   737 E C3282898:Tip [Qualitative Concept]

Phrase: "becoming"

Phrase: "randomly"

Phrase: "distributed throughout the cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1704711:Distributed [Functional Concept]
   770   C1948049:Cell [Spatial Concept]

Phrase: "within 5 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "(Fig. 6Ac"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that End4/Sla2 accumulation at cell ends"

Phrase: "might"

Phrase: "be"

Phrase: "mediated by active vesicular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0205177:Active [Functional Concept]
   770   C0205378:Vesicular [Qualitative Concept]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.177: Conversely, treatment with 40 M latA (Fig. 6Ab) for up to 1 hour did not affect Sla2-GFP end localization. 

Phrase: "Conversely,"

Phrase: "treatment with 40 M latA (Fig. 6Ab"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "for"

Phrase: "up to 1 hour"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442450:1 Hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Sla2-GFP end localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]
Processing 00000000.tx.178: Similarly, deletion of the actin binding talin-like domain has no effect on End4/Sla2 localization. 

Phrase: "Similarly,"

Phrase: "deletion of the actin binding talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "no effect on End4/Sla2 localization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.179: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.180: 6Ba, Sla2talin-GFP accumulates at both cell ends. 

Phrase: "6Ba,"

Phrase: "Sla2talin-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "accumulates at both cell ends."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1656978:cell end [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0444930:ends [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C2746065:End [Temporal Concept]
Processing 00000000.tx.181: Co-staining of Sla2talin-GFP and actin (Fig. 6C) shows accumulation of Sla2talin-GFP at both growing and not-growing ends. 

Phrase: "Co-staining of Sla2talin-GFP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(Fig. 6C"

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "accumulation of Sla2talin-GFP"

Phrase: "at both growing"

Phrase: "and"

Phrase: "not-growing ends."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0444930:ends [Spatial Concept]
   793 E C2746065:End [Temporal Concept]
   755 E C0205088:Terminal [Temporal Concept]
   755 E C1705314:Terminal [Manufactured Object]
   755 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.182: View larger version (54K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 6. 

Phrase: "6."
Processing 00000000.tx.184: Sla2-GFP localization depends on vesicular transport. 

Phrase: "Sla2-GFP localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "depends on vesicular transport."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1325417:vesicular transport [Cell Function]
   783 E C0887882:Transport Vesicles [Cell Component]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0205378:Vesicular [Qualitative Concept]
   770   C0725813:depend [Medical Device]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]
Processing 00000000.tx.185: (A) Sla2-GFP cells were treated with (a) ethanol and DMSO, (b) 40 M latA (10 minutes at 25C), (c) 100 g/ml of brefeldin A (BfA) (10 minutes at 25C), or (d) 100 g/ml BfA and 40 M latA (10 minutes at 25C). 

Phrase: "(A) Sla2-GFP cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "(a) ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "and"

Phrase: "DMSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "(b) 40 M latA (10 minutes at 25C"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0456692:/10 minutes [Temporal Concept]
   764   C1442446:10 Minutes [Temporal Concept]
   742   C0439232:minute [Temporal Concept]
   742   C0700321:minute [Quantitative Concept]
   742   C0702093:/minute [Temporal Concept]
   742   C1282918:Minute [Quantitative Concept]
   742   C2347166:Minute [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "(c) 100 g/ml of brefeldin A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(BfA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "(10 minutes at 25C"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0456692:/10 minutes [Temporal Concept]
   833   C1442446:10 Minutes [Temporal Concept]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or ("

Phrase: "d)"

Phrase: "100 g/ml BfA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   804   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "40 M latA (10 minutes at 25C"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0456692:/10 minutes [Temporal Concept]
   770   C1442446:10 Minutes [Temporal Concept]
   744   C0439232:minute [Temporal Concept]
   744   C0700321:minute [Quantitative Concept]
   744   C0702093:/minute [Temporal Concept]
   744   C1282918:Minute [Quantitative Concept]
   744   C2347166:Minute [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.186: BfA treatment delocalizes Sla2-GFP in 5 minutes. 

Phrase: "BfA treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0054036:Brefeldin A [Antibiotic,Organic Chemical]

Phrase: "delocalizes"

Phrase: "Sla2-GFP in 5 minutes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.187: Sla2-GFP de-localization is abolished by co-treatment with latA. 

Phrase: "Sla2-GFP de-localization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0011198:DE [Geographic Area]
   812   C0017480:DE [Geographic Area]
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]
   812   C3541240:DE [Idea or Concept]

Phrase: "is"

Phrase: "abolished by co-treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0814472:co-treatment [Health Care Activity]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with latA."
Processing 00000000.tx.188: (B) Localization of Sla2talin-GFP (a) and calcofluor staining (b). 

Phrase: "(B) Localization of Sla2talin-GFP ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "a)"

Phrase: "and"

Phrase: "calcofluor staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.189: Sla2talin-GFP cells treated with BfA at 25C for 10 minutes (c). 

Phrase: "Sla2talin-GFP cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with BfA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "at 25C"

Phrase: "for 10 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456692:/10 minutes [Temporal Concept]
  1000   C1442446:10 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "(c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.190: (C) Staining of Sla2talin-GFP-expressing cells with Rhodamine phalloidin. 

Phrase: "(C) Staining of Sla2talin-GFP-expressing cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "with Rhodamine phalloidin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1613323:rhodamine-phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0031312:Phalloidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.191: (D) Sla2-GFP local movement is abolished by treatment with 40 M latA. 

Phrase: "("

Phrase: "D)"

Phrase: "Sla2-GFP local movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026649:Movement [Organism Function]

Phrase: "is"

Phrase: "abolished by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with 40 M latA."
Processing 00000000.tx.192: Arrowheads point to the same GFP dot in different frames of a time-lapse recording (see Movie 1 in supplementary material; +latA frames are from Movie 2). 

Phrase: "Arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "point to the same GFP dot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0445247:Same [Qualitative Concept]
   753   C0872145:DOT [Therapeutic or Preventive Procedure]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]

Phrase: "in different frames"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0180979:frames [Medical Device]
   827 E C0080089:Frame [Nucleotide Sequence]
   827 E C1705858:Frame [Manufactured Object]

Phrase: "of a time-lapse recording"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Movie 1 in supplementary material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2936424:Supplementary Material [Intellectual Product]
   760   C0520510:Material [Substance]
   760   C0681495:Movie [Manufactured Object]

Phrase: "; +latA frames"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0180979:frames [Medical Device]
   793 E C0080089:Frame [Nucleotide Sequence]
   793 E C1705858:Frame [Manufactured Object]

Phrase: "are from Movie 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0681495:Movie [Manufactured Object]
   770   C1551058:Are [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.193: Bar, 5 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.194: However, similarly to budding yeast where latA treatment abolishes Sc-SLA2 movement (Kaksonen et al., 2003), the rapid and apparently random movement of Sla2-GFP dots near the cell cortex was completely blocked by addition of 40 M latA to the medium (Fig. 6D). 

Phrase: "However,"

Phrase: "similarly to budding yeast where latA treatment"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0014181:Yeast, Budding [Fungus]
   767 E C1961113:Yeast.budding [Fungus]
   744   C0036025:yeast [Fungus]
   744   C0039798:treatment [Functional Concept]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C1155616:budding [Cell Function]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
   711 E C2700462:Bud [Plant]
   711 E C2945744:bud [Anatomical Structure]

Phrase: "abolishes"

Phrase: "Sc-SLA2 movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026649:Movement [Organism Function]

Phrase: "(Kaksonen et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "the rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "apparently random movement of Sla2-GFP dots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026649:Movement [Organism Function]

Phrase: "near the cell cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1166657:cell cortex [Cell Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by addition of 40 M latA"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   767   C0213052:M 40 [Amino Acid, Peptide, or Protein]
   744   C0028778:Blocked [Pathologic Function]
   744   C0332206:Blocked [Functional Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439509:/40 [Temporal Concept]
   744   C0441923:M+ [Intellectual Product]
   744   C1883712:Addition [Functional Concept]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "to the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 6D"

Phrase: ")."
Processing 00000000.tx.195: BfA-dependent delocalization of Sla2-GFP was also suppressed by the simultaneous addition of 40 M latA (Fig. 6Ad), as well as by the deletion of the talin-like domain (Fig. 6Bc). 

Phrase: "BfA-dependent delocalization of Sla2-GFP"

Phrase: "was"

Phrase: "also"

Phrase: "suppressed by the simultaneous addition of 40 M latA (Fig. 6Ad"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C0213052:M 40 [Amino Acid, Peptide, or Protein]
   736   C0349966:Fig [Food]
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0439509:/40 [Temporal Concept]
   736   C0441923:M+ [Intellectual Product]
   736   C0521115:Simultaneous [Temporal Concept]
   736   C1260953:Suppressed [Functional Concept]
   736   C1337208:FIG [Food]
   736   C1548968:Simultaneous [Idea or Concept]
   736   C1883712:Addition [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "as well as by the deletion of the talin-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205170:Well [Qualitative Concept]
   742   C1420760:TALIN [Gene or Genome]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1880274:Deletion [Activity]
   742   C3146287:Well [Manufactured Object]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(Fig. 6Bc"

Phrase: ")."
Processing 00000000.tx.196: Thus End4/Sla2 localization requires active vesicular trafficking and is only maintained at cell ends for a short time of around 5 minutes. 

Phrase: "Thus End4/Sla2 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "requires"

Phrase: "active vesicular"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205378:Vesicular [Qualitative Concept]
   789 E C0333262:VESICLES [Acquired Abnormality]
   789 E C1622418:vesicle [Cell Component]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "maintained at cell"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0007634:Cell [Cell]
   790   C1269647:Cell [Cell]
   790   C1314677:Maintained [Functional Concept]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "ends for a short time of"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1522314:End Time [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0444930:End [Spatial Concept]
   753   C1282927:short [Qualitative Concept]
   753   C1806781:Short [Quantitative Concept]
   753   C2350002:Short [Quantitative Concept]
   753   C2746065:End [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "around 5 minutes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.197: We conclude that rapid removal of End4/Sla2 from cell ends requires the actin cytoskeleton and the talin-like domain.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that rapid removal of End4/Sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from cell ends"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "requires"

Phrase: "the actin cytoskeleton"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025979:Actin Cytoskeleton [Cell Component]
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "and"

Phrase: "the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.198: Discussion Top Summary Introduction Materials and Methods Results Discussion References  We have identified End4/Sla2 as a protein required to recruit actin and the growth machinery to the new cell end in fission yeast. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "identified End4/Sla2 as a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1424907:SLA2 [Gene or Genome]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recruit"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "the growth machinery to the new cell end"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0337076:machinery [Manufactured Object]

Phrase: "in fission yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.199: Phenotypic analysis of sla2 mutants showed that this gene is required for proper actin organization and cell morphogenesis. 

Phrase: "Phenotypic analysis of sla2 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "required for proper actin organization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1514873:Required [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "cell morphogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1156238:cell morphogenesis [Cell Function]
   861   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.200: Cells lacking End4/Sla2 have an aberrant shape and a depolarized cortical actin cytoskeleton. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "have"

Phrase: "an aberrant shape"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332479:Shape [Spatial Concept]
   861   C0348078:shape [Qualitative Concept]
   861   C0522512:Shape [Spatial Concept]

Phrase: "and"

Phrase: "a depolarized cortical actin cytoskeleton."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1325547:Cortical actin cytoskeleton [Cell Component]
   875   C1325546:Cortical cytoskeleton [Cell Component]
   861   C0025979:Actin Cytoskeleton [Cell Component]
   812   C0010853:Cytoskeleton [Cell Component]
   812   C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.201: This phenotype is reminiscent of that shown by deletion of Sc-sla2. 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "reminiscent of that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0871247:reminiscence [Mental Process]

Phrase: "shown by deletion of Sc-sla2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1424907:SLA2 [Gene or Genome]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.202: In budding yeast, sla2 cells are spherical and have delocalized cortical actin structures, with aggregated actin patches dispersed throughout the cytoplasm (Holtzman et al., 1993). 

Phrase: "In budding yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014181:Yeast, Budding [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "sla2 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "spherical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332501:Spherical [Spatial Concept]

Phrase: "and"

Phrase: "have"

Phrase: "delocalized cortical actin structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]

Phrase: "with aggregated actin patches"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   884   C1166660:actin patch [Cell Component]
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]

Phrase: "dispersed throughout the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0332624:Dispersed [Spatial Concept]

Phrase: "(Holtzman et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.203: Deletion of Sc-sla2 also caused defects in endocytosis (Wesp et al., 1997). 

Phrase: "Deletion of Sc-sla2 also caused defects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "in endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "(Wesp et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.204: Sc-SLA2 is involved in the internalization step of endocytosis (Kaksonen et al., 2003; Raths et al., 1993), but does not require its C-terminal talin-like domain for bulk lipid endocytosis (Baggett et al., 2003). 

Phrase: "Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "involved in the internalization step of endocytosis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0014139:Endocytosis [Cell Function]
   748   C0871786:internalization [Mental Process]
   748   C1261552:Step [Conceptual Entity]
   748   C1314939:Involved [Functional Concept]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]
   748   C2984285:Endocytosis [Functional Concept]

Phrase: "(Kaksonen et al.,"

Phrase: "2003"

Phrase: "; Raths et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "its C-terminal talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "for bulk lipid endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014139:Endocytosis [Cell Function]
   827   C2984285:Endocytosis [Functional Concept]

Phrase: "(Baggett et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.205: Recent work by Iwaki et al. showed that in fission yeast, End4/Sla2 is also required for endocytosis (Iwaki et al., 2004). 

Phrase: "Recent work by Iwaki et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043227:Work [Occupational Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in fission yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178453:Yeast, Fission [Fungus]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "required for endocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014139:Endocytosis [Cell Function]
   790   C1514873:Required [Functional Concept]
   790   C2984285:Endocytosis [Functional Concept]

Phrase: "(Iwaki et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.206: Deletion of the end4/sla2 gene inhibits delivery of FM4-64 to the vacuolar membrane, accumulation of luciferase yellow CH and internalization of the membrane protein Map3 (Iwaki et al., 2004). 

Phrase: "Deletion of the end4/sla2 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0017260:Gene Deletion [Genetic Function]
   783   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "delivery of FM4-64"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011209:Delivery [Therapeutic or Preventive Procedure]
   770   C0559563:delivery [Finding]
   770   C1705822:Delivery [Activity]

Phrase: "to the vacuolar membrane,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1167041:vacuolar membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0042219:Vacuolar [Cell Component]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "accumulation of luciferase yellow CH"

Phrase: "and"

Phrase: "internalization of the membrane protein Map3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871786:internalization [Mental Process]

Phrase: "(Iwaki et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.207: Although we cannot exclude a defect in receptor-mediated endocytosis as is observed in S. cerevisiae at elevated temperatures (Baggett et al., 2003), we observed no defects in fluid phase endocytosis (assayed by FM4-64 uptake) when the C-terminal talin-like domain of End4/Sla2 was deleted. 

Phrase: "Although"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a defect in receptor-mediated endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]

Phrase: "as is"

Phrase: "observed in S. cerevisiae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "at elevated temperatures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0015967:elevated temperature [Finding]
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "(Baggett et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no defects in fluid phase endocytosis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0243067:defects [Functional Concept]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "("

Phrase: "assayed by FM4-64 uptake"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0294936:FM4-64 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C1424293:FM4 [Gene or Genome]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: "when"

Phrase: "the C-terminal talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "of End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "was"

Phrase: "deleted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]
Processing 00000000.tx.208: Our analysis of the sla2talin strain instead uncovered a novel function for End4/Sla2 in establishment of new growth zones in fission yeast. 

Phrase: "Our analysis of the sla2talin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "strain"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "instead"

Phrase: "uncovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439845:Uncovered [Functional Concept]

Phrase: "a novel function for End4/Sla2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "in establishment"

Phrase: "of new growth zones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1710706:Zone [Spatial Concept]
   743 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0027651:New growth [Neoplastic Process]

Phrase: "in fission yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.209: Moreover, in contrast with previous work in S. cerevisiae (Yang et al., 1999) and in Candida albicans (Asleson et al., 2001), which attributed only a marginal role to the talin-like domain, our data suggest a role for the talin-like domain in the recruitment of actin and activation of growth at new cell ends. 

Phrase: "Moreover,"

Phrase: "in contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "with previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "in S. cerevisiae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036025:S cerevisiae [Fungus]

Phrase: "(Yang et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "and in Candida albicans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0006837:Candida albicans [Fungus]
   770   C0006836:Candida [Fungus]
   770   C1515981:And [Idea or Concept]

Phrase: "(Asleson et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a marginal role to the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "like domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "in the recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "activation of growth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2249824:activation of growth [Organism Function]
   790   C1879547:Activation [Activity]

Phrase: "at new cell ends."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   988   C3159040:new cell end [Cell Component]
   884   C1656978:cell end [Cell Component]
   827   C0444930:ends [Spatial Concept]
   793 E C2746065:End [Temporal Concept]
   755 E C0205088:Terminal [Temporal Concept]
   755 E C1705314:Terminal [Manufactured Object]
   755 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.210: Sla2talin cells are, in fact, NETO defective, with monopolar actin patches. 

Phrase: "Sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: ","

Phrase: "in fact,"

Phrase: "NETO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657233:NETO [Cell Function]

Phrase: "defective,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332452:Defective [Functional Concept]

Phrase: "with monopolar actin patches."
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   884   C1166660:actin patch [Cell Component]
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]
Processing 00000000.tx.211: End4/Sla2 talin-like domain mutant cells fail to activate growth at the new end but do polarize growth at the old end and grow in a monopolar fashion. 

Phrase: "End4/Sla2 talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420760:TALIN [Gene or Genome]

Phrase: "like domain mutant cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "growth at the new end"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0027651:New growth [Neoplastic Process]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "do"

Phrase: "polarize"

Phrase: "growth at the old end"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "grow in a monopolar fashion."
Processing 00000000.tx.212: Unlike ssp1 cells, which can activate bipolar growth upon latA treatment (Rupes et al., 1999), sla2talin cells have lost their intrinsic ability to activate growth at the new end, and their NETO defect cannot be overcome by an artificial increase in free actin monomers. 

Phrase: "Unlike ssp1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "bipolar growth upon latA treatment"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1326221:bipolar growth [Cell Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0220844:growth [Physiologic Function]
   753   C0443156:Bipolar [Spatial Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1705169:Treatment [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(Rupes et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "sla2talin cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their intrinsic ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "growth at the new end,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0027651:New growth [Neoplastic Process]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "their NETO defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "cannot"

Phrase: "be"

Phrase: "overcome by an artificial increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2983310:Overcome [Activity]

Phrase: "in free actin monomers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:monomers [Chemical Viewed Structurally]
Processing 00000000.tx.213: Hence End4/Sla2 has an essential role in linking actin organization and growth. 

Phrase: "Hence End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424907:SLA2 [Gene or Genome]

Phrase: "has"

Phrase: "an essential role in linking actin organization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]
Processing 00000000.tx.214: Since the truncated protein localizes to both the growing and the non-growing end, however, the role played by the talin-like domain might be restricted to establishment of bipolar growth. 

Phrase: "Since"

Phrase: "the truncated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "localizes to both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392752:localize [Spatial Concept]

Phrase: "the growing"

Phrase: "and"

Phrase: "the non-growing end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0444930:End [Spatial Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "however,"

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "played by the talin-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600138:played [Finding]
   770   C1420760:TALIN [Gene or Genome]
   737 E C0032214:Play [Daily or Recreational Activity]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "might"

Phrase: "be"

Phrase: "restricted to establishment of bipolar growth."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1326221:bipolar growth [Cell Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0443156:Bipolar [Spatial Concept]
   753   C0443288:Restricted [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
Processing 00000000.tx.215: As the talin-like domain binds actin both in vitro (McCann and Craig, 1999) and in two-hybrid assays (Yang et al., 1999), it is tempting to suggest that End4/Sla2 acts downstream of the polarity machinery at the interface with actin, and that the NETO defect seen in sla2talin cells is due to the inability of the truncated protein to either polymerize or stabilize actin at the new end despite the presence of polarity markers. 

Phrase: "As the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(McCann"

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "1999"

Phrase: ")"

Phrase: "and in two-hybrid assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0752172:Two-Hybrid Assays [Molecular Biology Research Technique]
   806   C0599647:Two Hybrid [Molecular Biology Research Technique]
   760   C0020205:Hybrid [Organism]
   760   C0205448:Two [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(Yang et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "acts downstream of the polarity machinery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0337076:machinery [Manufactured Object]
   753   C0522506:Downstream [Spatial Concept]
   753   C0596963:Polarity [Quantitative Concept]

Phrase: "at the interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708533:Interface [Manufactured Object]
  1000   C2698172:Interface [Intellectual Product]

Phrase: "with actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the NETO defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "seen in sla2talin cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "is due to the inability of the truncated protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C3146286:Due [Idea or Concept]

Phrase: "to either"

Phrase: "polymerize"

Phrase: "or"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "actin at the new end"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of polarity markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.216: However, given that it has also been suggested that the talin-like domain is required for protein-protein interaction and regulation of Sc-SLA2 activity (Yang et al., 1999), an alternative explanation could be that the truncated form is inactive or unable to interact with the growth machinery. 

Phrase: "However,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "it"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for protein-protein interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514873:Required [Functional Concept]
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "regulation of Sc-SLA2 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(Yang et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "an alternative explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "that"

Phrase: "the truncated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "or"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "interact with the growth machinery."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C0337076:machinery [Manufactured Object]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
Processing 00000000.tx.217: Full deletion of Sla2/End4, which affects endocytosis as well as actin organization, leads to complete loss of polarity, whereas deletion of the talin-like domain, which does not interfere with bulk endocytosis, does not affect polarized growth but does influence establishment of new sites of polarized growth. 

Phrase: "Full deletion of Sla2/End4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "which"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "as well as"

Phrase: "actin organization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "loss of polarity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "whereas"

Phrase: "deletion of the talin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "like domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with bulk endocytosis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012173:Bulk [Food]
   770   C0014139:Endocytosis [Cell Function]
   770   C0521102:Interfere [Qualitative Concept]
   770   C1337615:Bulk [Biomedical or Dental Material]
   770   C2984285:Endocytosis [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "polarized growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "does"

Phrase: "influence establishment of new sites of polarized growth."
Processing 00000000.tx.218: Interestingly in budding yeast, sla2-6 mutant cells, which, unlike sla2 cells, grow well at all temperatures and show polarized actin, exhibit a bipolar budding defect (Yang et al., 1997). 

Phrase: "Interestingly in budding yeast,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0014181:Yeast, Budding [Fungus]
   819 E C1961113:Yeast.budding [Fungus]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1155616:budding [Cell Function]
   737 E C2700462:Bud [Plant]
   737 E C2945744:bud [Anatomical Structure]

Phrase: "sla2-6 mutant cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which,"

Phrase: "unlike sla2 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "grow"

Phrase: "well at all temperatures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0039476:Temperatures [Quantitative Concept]
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C0005903:temperature [Organism Attribute]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "polarized actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a bipolar budding defect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]
   734   C1749576:bipolar budding [Cell Function]

Phrase: "(Yang et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.219: This suggests that in both fission and budding yeast Sla2 might have two independent functions: to maintain polarized cell growth (requiring the full length protein) and to promote NETO/distal budding. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in both fission"

Phrase: "and"

Phrase: "budding yeast Sla2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1424907:SLA2 [Gene or Genome]
   734   C0014181:Yeast, Budding [Fungus]

Phrase: "might"

Phrase: "have"

Phrase: "two independent functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "polarized cell growth"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1155893:polarized cell growth [Cell Function]
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   734   C0598102:polarized cell [Cell]

Phrase: "("

Phrase: "requiring"

Phrase: "the full length protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NETO/distal budding."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1155616:budding [Cell Function]
   793 E C2700462:Bud [Plant]
   793 E C2945744:bud [Anatomical Structure]
Processing 00000000.tx.220: Formally, however it is also possible, at least in S. pombe, that End4/Sla2 is required only for establishment of polarized growth, with activation at the new end requiring a higher level of activity and therefore being more readily affected by alteration of the protein, such as the deletion of the talin-like domain. 

Phrase: "Formally,"

Phrase: "however"

Phrase: "it"

Phrase: "is"

Phrase: "also possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in S. pombe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178453:S pombe [Fungus]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "only for establishment of polarized growth,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205171:Only [Quantitative Concept]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1720467:Only [Intellectual Product]
   753   C2911660:Growth [Activity]

Phrase: "with activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "at the new end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "requiring"

Phrase: "a higher level of activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0683317:Activity level [Finding]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "therefore"

Phrase: "being"

Phrase: "more readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "affected by alteration of the protein,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1515926:Alteration [Idea or Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "such as the deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "of the talin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "like domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.221: As previously suggested for Orb3, Orb8 and Orb9 (Snell and Nurse, 1994; Verde et al., 1995), End4/Sla2 might be required to reorganize the actin cytoskeleton after a major cell cycle transition, such as mitosis. 

Phrase: "As"

Phrase: "previously"

Phrase: "suggested for Orb3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1428682:ORB3 [Gene or Genome]
   756   C1705535:Suggest [Idea or Concept]

Phrase: "Orb8"

Phrase: "and"

Phrase: "Orb9"

Phrase: "(Snell"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1994"

Phrase: "; Verde et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reorganize"

Phrase: "the actin cytoskeleton after a major cell cycle transition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0025979:Actin Cytoskeleton [Cell Component]
   742   C0010853:Cytoskeleton [Cell Component]
   742   C1748451:Cytoskeleton [Cell Component]

Phrase: "such as mitosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026255:Mitosis [Cell Function]
   928 E C1513354:Mitotic [Qualitative Concept]
Processing 00000000.tx.222: Remarkably the general loss of polarization observed in sla2 cells resembles that shown by orb mutants at restrictive temperature (Snell and Nurse, 1994; Verde et al., 1995). 

Phrase: "Remarkably"

Phrase: "the general loss of polarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "observed in sla2 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1424907:SLA2 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "resembles"

Phrase: "that"

Phrase: "shown by orb mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449209:ORB [Body Location or Region]
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   737   C1547282:Show [Intellectual Product]

Phrase: "at restrictive temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "(Snell"

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1994"

Phrase: "; Verde et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.223: Interestingly most of the orb genes identified so far encode protein kinases and Sc-SLA2 is phosphorylated (Ficarro et al., 2002) in logarithmically growing cells. 

Phrase: "Interestingly most of the orb genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017337:Genes [Gene or Genome]
   753   C0449209:ORB [Body Location or Region]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Sc-SLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "(Ficarro et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "in logarithmically growing cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: This phosphorylation has been suggested as a potential regulatory switch to trigger End4/Sla2-actin interaction at the cell cortex (Yang et al., 1999) making End4/Sla2 a candidate downstream target of the Orb morphogenetic pathway. 

Phrase: "This phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as a potential regulatory switch to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]
   748   C1707719:Switch [Manufactured Object]
   748   C3245505:Potential [Qualitative Concept]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "End4/Sla2-actin interaction at the cell cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0007582:Cell Interaction [Cell Function]
   744   C1704675:Interaction [Functional Concept]

Phrase: "(Yang et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "making End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424907:SLA2 [Gene or Genome]

Phrase: "a candidate downstream target of the Orb morphogenetic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.225: In the rod-shaped fission yeast it is thought that the plus ends of microtubules define cell ends by delivering polarity markers such as Tea1 (Mata and Nurse, 1997). 

Phrase: "In the rod-shaped fission yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0178453:Yeast, Fission [Fungus]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "the plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "ends of microtubules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026046:Microtubules [Cell Component]
   790   C0444930:End [Spatial Concept]
   790   C2746065:End [Temporal Concept]

Phrase: "define"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "ends by delivering polarity markers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0444930:End [Spatial Concept]
   760   C0596963:Polarity [Quantitative Concept]
   760   C2746065:End [Temporal Concept]
   726   C0005516:Marker [Clinical Attribute]
   726   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726   C1705822:Deliver [Activity]
   726   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "such as Tea1"

Phrase: "(Mata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.226: End4/Sla2 in also enriched at cell ends during interphase and is therefore a good candidate to play a direct role in the recruitment/assembly of cortical polar actin. 

Phrase: "End4/Sla2 in also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1424907:SLA2 [Gene or Genome]

Phrase: "enriched at cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0007634:Cell [Cell]
   790   C0359583:enriched [Food]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]

Phrase: "ends during interphase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021798:Interphase [Cell Function]
   790   C0444930:End [Spatial Concept]
   790   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "therefore"

Phrase: "a good candidate to"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a direct role in the recruitment/assembly of cortical polar actin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.227: Consistently, End4/Sla2 end localization is independent of microtubules but requires Tea1 to recognize the end where growth has not previously occurred. 

Phrase: "Consistently,"

Phrase: "End4/Sla2 end localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "is independent of microtubules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332291:Independent of [Functional Concept]
   770   C0026046:Microtubules [Cell Component]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]

Phrase: "but"

Phrase: "requires"

Phrase: "Tea1 to"

Phrase: "recognize"

Phrase: "the end where growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "has"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.228: Cells lacking Tea1 do not accumulate End4/Sla2 at the new end and fail to undergo NETO. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "Tea1"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accumulate"

Phrase: "End4/Sla2 at the new end"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1424907:SLA2 [Gene or Genome]

Phrase: "and"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "NETO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657233:NETO [Cell Function]
Processing 00000000.tx.229: Therefore our work places End4/Sla2 as a link between microtubules and the machinery involved in sensing overall cell space and the actin cytoskeleton, which leads to polarized growth. 

Phrase: "Therefore"

Phrase: "our work places End4/Sla2 as a link"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1424907:SLA2 [Gene or Genome]

Phrase: "between microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "and"

Phrase: "the machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337076:machinery [Manufactured Object]

Phrase: "involved in sensing overall cell space"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1179886:Cell space [Body Space or Junction]
   753   C0007634:Cell [Cell]
   753   C0282416:Overall [Intellectual Product]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1561607:Overall [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1883067:Space [Spatial Concept]
   753   C1948049:Cell [Spatial Concept]
   719   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "the actin cytoskeleton,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025979:Actin Cytoskeleton [Cell Component]
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "which"

Phrase: "leads to polarized growth."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0220844:growth [Physiologic Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C2911660:Growth [Activity]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.230: In this model Tea1 would mark new sites of cell growth and recruit End4/Sla2, which in turn could initiate accumulation of cortical actin. 

Phrase: "In this model Tea1"

Phrase: "would"

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "new sites of cell growth"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "recruit End4/Sla2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1424907:SLA2 [Gene or Genome]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "could"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "accumulation of cortical actin."
Processing 00000000.tx.231: Tea1 and End4/Sla2 only partially colocalize at cell ends. 

Phrase: "Tea1"

Phrase: "and"

Phrase: "End4/Sla2 only partially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205171:Only [Quantitative Concept]
   812   C1424907:SLA2 [Gene or Genome]
   812   C1720467:Only [Intellectual Product]

Phrase: "colocalize at cell ends."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C1656978:cell end [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0444930:ends [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C2746065:End [Temporal Concept]
Processing 00000000.tx.232: However, if Tea1 is only required for the initial recruitment of End4/Sla2 but not for its maintenance at cell ends, their interaction could be only transient, and no longer be necessary once the End4/Sla2-cortex interaction was established. 

Phrase: "However,"

Phrase: "if"

Phrase: "Tea1"

Phrase: "is"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "required for the initial recruitment of End4/Sla2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205265:Initial [Temporal Concept]
   744   C1279901:Initial [Qualitative Concept]
   744   C1424907:SLA2 [Gene or Genome]
   744   C1514873:Required [Functional Concept]
   744   C1555582:Initial [Idea or Concept]
   744   C1705685:INITIAL [Functional Concept]
   744   C2949735:Recruitment [Activity]

Phrase: "but"

Phrase: "not for its maintenance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024501:Maintenance [Activity]
   770   C1518422:Not [Functional Concept]

Phrase: "at cell ends,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1656978:cell end [Cell Component]
   861   C0444930:ends [Spatial Concept]
   827 E C2746065:End [Temporal Concept]
   789 E C0205088:Terminal [Temporal Concept]
   789 E C1705314:Terminal [Manufactured Object]
   789 E C1705315:Terminal [Spatial Concept]

Phrase: "their interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "only transient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040704:Transient [Population Group]
   861   C0205374:Transient [Temporal Concept]

Phrase: "and"

Phrase: "no longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "be"

Phrase: "necessary once"

Phrase: "the End4/Sla2-cortex interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.233: The functional interaction between Tea1 and End4/Sla2 might reflect a direct physical interaction, and consistent with this we could detect a direct interaction between the C terminus of Tea1 and End4/Sla2 in a two-hybrid assay (our unpublished observation), although we could not confirm it in vitro in fission yeast cell extracts. 

Phrase: "The functional interaction between Tea1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a direct physical interaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1167622:Physical Interaction [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "consistent with this"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a direct interaction between the C terminus of Tea1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "End4/Sla2 in a two-hybrid assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1424907:SLA2 [Gene or Genome]

Phrase: "("

Phrase: "our unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "it in vitro in fission yeast cell extracts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.234: It is also possible that End4/Sla2 acts in conjunction with other factors such as Bud6, a factor required for NETO and shown to physically associate with Tea1 (Glynn et al., 2001). 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "acts in conjunction with other factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C2699427:Conjunction [Idea or Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "such as Bud6,"

Phrase: "a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "required for NETO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514873:Required [Functional Concept]
   790   C1657233:NETO [Cell Function]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "associate with Tea1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "(Glynn et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.235: Interestingly, bud6 and sla2talin show the same growth patter (Glynn et al., 2001). 

Phrase: "Interestingly,"

Phrase: "bud6"

Phrase: "and"

Phrase: "sla2talin"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same growth patter"

Phrase: "(Glynn et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.236: Moreover, the proper localization of both Bud6 (Jin and Amberg, 2000) and End4/Sla2 (BfA experiment, this study) is mediated by the secretory pathway and requires Tea1. 

Phrase: "Moreover,"

Phrase: "the proper localization of both Bud6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "(Jin"

Phrase: "and"

Phrase: "Amberg,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "End4/Sla2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424907:SLA2 [Gene or Genome]

Phrase: "(BfA experiment,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]
   734   C0054036:Brefeldin A [Antibiotic,Organic Chemical]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "is"

Phrase: "mediated by the secretory pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1159342:Secretory Pathway [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1327616:Secretory [Cell Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "requires"

Phrase: "Tea1."
Processing 00000000.tx.237: Interestingly, it was postulated that the secretion and endocytosis might be coupled: the secretory pathway being required to replenish components needed at the plasma membrane for endocytosis (Riezman, 1985). 

Phrase: "Interestingly,"

Phrase: "it"

Phrase: "was"

Phrase: "postulated"

Phrase: "that"

Phrase: "the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: ":"

Phrase: "the secretory pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "being"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replenish"

Phrase: "components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "needed at the plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0027552:Needed [Qualitative Concept]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C0686904:needed [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "for endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "(Riezman,"

Phrase: "1985"

Phrase: ")."
Processing 00000000.tx.238: However, S. cerevisiae end3 mutant cells, which are defective in endocytosis, still grow and therefore have an active secretion pathway (Raths et al., 1993). 

Phrase: "However,"

Phrase: "S. cerevisiae end3 mutant cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "are"

Phrase: "defective in endocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332452:Defective [Functional Concept]

Phrase: "still"

Phrase: "grow"

Phrase: "and"

Phrase: "therefore"

Phrase: "have"

Phrase: "an active secretion pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1159342:Secretion Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(Raths et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.239: Although the coupling might not be essential, a functional link might still exist. 

Phrase: "Although"

Phrase: "the coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "essential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205224:Essential [Qualitative Concept]

Phrase: "a functional link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1517892:Link [Intellectual Product]
   861   C1704666:Link [Intellectual Product]

Phrase: "might"

Phrase: "still"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.240: Localized secretion may be required to accumulate proteins at sites of growth, and localised endocytosis could define and delimit the growth zone to cell tips by removing excess factors from neighbouring areas. 

Phrase: "Localized secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate"

Phrase: "proteins at sites of growth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "localised endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014139:Endocytosis [Cell Function]
   861   C2984285:Endocytosis [Functional Concept]

Phrase: "could"

Phrase: "define"

Phrase: "and"

Phrase: "delimit"

Phrase: "the growth zone to cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1183408:Cell zone [Cell Component]
   760   C1710706:Zone [Spatial Concept]

Phrase: "tips by removing excess factors"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0339897:TIPS [Therapeutic or Preventive Procedure]
   760   C1710425:Tip [Medical Device]
   760   C1979886:Excess [Qualitative Concept]
   760   C3282898:Tip [Qualitative Concept]
   726   C0849355:remove [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C1883720:Remove [Activity]
   726   C2827422:Factor [Conceptual Entity]
   726   C3244314:remove [Functional Concept]

Phrase: "from neighbouring areas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]
Processing 00000000.tx.241: In this scenario, depolarized endocytosis would result in loss of cellular domains and consequently in loss of polarity, as seen in sla2 cells. 

Phrase: "In this scenario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "depolarized endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014139:Endocytosis [Cell Function]
   861   C2984285:Endocytosis [Functional Concept]

Phrase: "would"

Phrase: "result in loss of cellular domains"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1517945:Loss [Quantitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "consequently in loss of polarity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596963:Polarity [Quantitative Concept]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "as"

Phrase: "seen in sla2 cells."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C1424907:SLA2 [Gene or Genome]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.242: Studies in other organisms have shown that, as in fission yeast, Sla2 homologues are enriched in subcellular regions, which show elevated membrane turnover and actin accumulation. 

Phrase: "Studies in other organisms"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "as in fission yeast,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178453:Yeast, Fission [Fungus]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "Sla2 homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "are"

Phrase: "enriched in subcellular regions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0359583:enriched [Food]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "elevated membrane turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "actin accumulation."
Processing 00000000.tx.243: Hip1, the human homologue of Sla2, colocalizes with and binds to clathrin and adaptor protein-2 (AP2) (Engqvist-Goldstein et al., 2001; Mishra et al., 2001), both highly enriched at presynaptic nerve terminals, where they facilitate rapid retrieval of synaptic vesicles (De Camilli et al., 2001; Sun et al., 2002). 

Phrase: "Hip1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415546:HIP1 [Gene or Genome]
  1000   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the human homologue of Sla2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologue [Gene or Genome]

Phrase: "colocalizes with"

Phrase: "and"

Phrase: "binds to clathrin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "adaptor protein-2 (AP2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1706710:Adaptor [Manufactured Object]

Phrase: "(Engqvist-Goldstein et al.,"

Phrase: "2001"

Phrase: "; Mishra et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "both highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "enriched at presynaptic nerve terminals,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0027747:Nerve terminals [Cell Component]
   797   C0206181:Presynaptic Terminals [Cell Component]
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C0359583:enriched [Food]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   726   C0205088:Terminal [Temporal Concept]
   726   C1705314:Terminal [Manufactured Object]
   726   C1705315:Terminal [Spatial Concept]
   704 E C0599851:Neural [Functional Concept]

Phrase: "where"

Phrase: "they"

Phrase: "facilitate"

Phrase: "rapid retrieval of synaptic vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1154468:synaptic vesicle retrieval [Cell Function]
   760   C1514918:Retrieval [Health Care Activity]

Phrase: "(De Camilli et al.,"

Phrase: "2001"

Phrase: "; Sun et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.244: Hip1 was identified through its interaction with huntingtin (Kalchman et al., 1997; Wanker et al., 1997), a protein containing a polyglutamine stretch. 

Phrase: "Hip1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415546:HIP1 [Gene or Genome]
  1000   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "identified through its interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "(Kalchman et al.,"

Phrase: "1997"

Phrase: "; Wanker et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a polyglutamine stretch."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600080:stretch [Therapeutic or Preventive Procedure]
Processing 00000000.tx.245: Polyglutamine expansion causes a decrease in the Hip1-huntingtin interaction and is associated with the onset of Huntington's disease (HD). 

Phrase: "Polyglutamine expansion"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in the Hip1-huntingtin interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "associated with the onset of Huntington's disease"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0020179:Huntington Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C2919056:Huntington's Disease [Functional Concept]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(HD"

Phrase: ")."
Processing 00000000.tx.246: Huntingtin, like Tea1, associates with microtubules (Gutekunst et al., 1995; Hoffner et al., 2002; Muchowski et al., 2002; Tukamoto et al., 1997), and so Sla2/Hip1 family proteins may have a conserved role working at the interface between the actin and microtubular networks.  

Phrase: "Huntingtin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "like Tea1,"

Phrase: "associates with microtubules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026046:Microtubules [Cell Component]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "(Gutekunst et al.,"

Phrase: "1995"

Phrase: "; Hoffner et al.,"

Phrase: "2002"

Phrase: "; Muchowski et al.,"

Phrase: "2002"

Phrase: "; Tukamoto et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "so Sla2/Hip1 family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "have"

Phrase: "a conserved role working at the interface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0043227:Working [Occupational Activity]

Phrase: "between the actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "microtubular networks."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]
Processing 00000000.tx.247: Acknowledgments  We thank all members of the Nurse lab for help and discussion. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all members of the Nurse lab"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "for"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "discussion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.248: Special thanks to J. 

Phrase: "Special"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205555:Special [Qualitative Concept]

Phrase: "thanks to J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986676:THANK [Gene or Genome]
Processing 00000000.tx.249: Hayles, K. 

Phrase: "Hayles,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.250: Leonhard, R. 

Phrase: "Leonhard,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.251: Carazo-Salas and M. 

Phrase: "Carazo-Salas"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.252: Pardo for valuable comments on the manuscript. 

Phrase: "Pardo for valuable comments"

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.253: S.C. was supported by a Marie Curie postdoctoral fellowship and by a CRUK postdoctoral fellowship. 

Phrase: "S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "was"

Phrase: "supported by a Marie Curie postdoctoral fellowship"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0015770:Fellowship [Educational Activity]
   748   C0700085:Curie [Quantitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "and by a CRUK postdoctoral fellowship."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015770:Fellowship [Educational Activity]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.254: R.B. was supported by ICRF and by a Boehringer Ingelheim Fonds fellowship.  

Phrase: "R.B."

Phrase: "was"

Phrase: "supported by ICRF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "and by a Boehringer Ingelheim Fonds fellowship."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0331792:Boehringer Ingelheim [Health Care Related Organization]
   748   C0015770:Fellowship [Educational Activity]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.255: Footnotes  Supplementary material available online at http://jcs.biologists.org/cgi/content/full/118/9/1843/DC1  References Top Summary Introduction Materials and Methods Results Discussion References  Alfa, C. 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Supplementary material available online at http"

Phrase: ":"

Phrase: "//jcs.biologists.org/cgi/content/full/118/9/1843/DC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1415570:DC1 [Gene or Genome]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alfa,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439095:Alpha [Intellectual Product]
  1000   C2003941:Alpha [Intellectual Product]
  1000   C2350010:Alpha [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.256: E., Gallagher, I. 

Phrase: "E.,"

Phrase: "Gallagher,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.257: M. and Hyams, J. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hyams,"

Phrase: "J."
Processing 00000000.tx.258: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.259: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.260: Antigen localization in fission yeast. 

Phrase: "Antigen localization in fission yeast."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.261: Methods Cell. 

Phrase: "Methods Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.262: Biol. 

Phrase: "Biol."
Processing 00000000.tx.263: 37, 201-222.[Medline] Asleson, C. 

Phrase: "37,"

Phrase: "201-222."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Asleson,"

Phrase: "C."
Processing 00000000.tx.264: M., Bensen, E. 

Phrase: "M."

Phrase: ","

Phrase: "Bensen,"

Phrase: "E."
Processing 00000000.tx.265: S., Gale, C. 

Phrase: "S."

Phrase: ","

Phrase: "Gale,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751161:GALE [Disease or Syndrome]
  1000   C1439333:GALE [Gene or Genome]
   944 E C0036262:Scabies [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.266: A., Melms, A. 

Phrase: "A.,"

Phrase: "Melms,"

Phrase: "A."
Processing 00000000.tx.267: S., Kurischko, C. and Berman, J. 

Phrase: "S."

Phrase: ","

Phrase: "Kurischko,"

Phrase: "C."

Phrase: "and"

Phrase: "Berman,"

Phrase: "J."
Processing 00000000.tx.268: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.269: Candida albicans INT1-induced filamentation in Saccharomyces cerevisiae depends on Sla2p. 

Phrase: "Candida albicans INT1-induced filamentation in Saccharomyces cerevisiae"

Phrase: "depends on Sla2p."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]
Processing 00000000.tx.270: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.271: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.272: Biol. 

Phrase: "Biol."
Processing 00000000.tx.273: 21, 1272-1284.[Abstract/Free FullText] Baggett, J. 

Phrase: "21,"

Phrase: "1272-1284."

Phrase: "[Abstract/Free FullText"

Phrase: "] Baggett,"

Phrase: "J."
Processing 00000000.tx.274: J., D'Aquino, K. 

Phrase: "J.,"

Phrase: "D'"

Phrase: "Aquino,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.275: E. and Wendland, B. 

Phrase: "E."

Phrase: "and"

Phrase: "Wendland,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.276: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.277: The Sla2p talin domain plays a role in endocytosis in Saccharomyces cerevisiae. 

Phrase: "The Sla2p talin domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in Saccharomyces cerevisiae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036025:Saccharomyces cerevisae [Fungus]
   861   C0036024:Saccharomyces [Fungus]
Processing 00000000.tx.278: Genetics 165, 1661-1674.[Abstract/Free FullText] Bahler, J., Wu, J. 

Phrase: "Genetics 165,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "1661-1674."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bahler,"

Phrase: "J.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.279: Q., Longtine, M. 

Phrase: "Q., Longtine,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: S., Shah, N. 

Phrase: "S."

Phrase: ","

Phrase: "Shah,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.281: G., McKenzie, A., 3rd, Steever, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McKenzie,"

Phrase: "A.,"

Phrase: "3rd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:3rd [Quantitative Concept]

Phrase: "Steever,"

Phrase: "A."
Processing 00000000.tx.282: B., Wach, A., Philippsen, P. and Pringle, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wach,"

Phrase: "A.,"

Phrase: "Philippsen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Pringle"

Phrase: ","

Phrase: "J."
Processing 00000000.tx.283: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.284: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.285: Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. 

Phrase: "Heterologous modules for efficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709061:Module [Conceptual Entity]

Phrase: "and"

Phrase: "versatile PCR-based gene targeting in Schizosaccharomyces pombe."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0242613:Gene Targeting [Molecular Biology Research Technique]
   750 E C1332838:Target Gene [Gene or Genome]
   744   C1521840:Targeting [Functional Concept]
   711 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.286: Yeast 14, 943-951.[CrossRef][Medline] Behrens, R. and Nurse, P. 

Phrase: "Yeast 14,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "943-951."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Behrens,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.287: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.288: Roles of fission yeast tea1p in the localization of polarity factors and in organizing the microtubular cytoskeleton. 

Phrase: "Roles of fission yeast tea1p"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in the localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "of polarity factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and in organizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1300196:organizing [Functional Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "the microtubular cytoskeleton."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.291: 157, 783-793.[Abstract/Free FullText] Brazer, S. 

Phrase: "157,"

Phrase: "783-793."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brazer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336113:Brazer [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.292: C., Williams, H. 

Phrase: "C., Williams,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.293: P., Chappell, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chappell,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.294: G. and Cande, W. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cande,"

Phrase: "W."
Processing 00000000.tx.295: Z. 

Phrase: "Z."
Processing 00000000.tx.296: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.297: A fission yeast kinesin affects Golgi membrane recycling. 

Phrase: "A fission yeast kinesin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085139:Kinesin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1622129:kinesin [Molecular Function]
   734   C0178453:Yeast, Fission [Fungus]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Golgi membrane recycling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0282114:Recycling [Human-caused Phenomenon or Process]
   734   C0230764:Golgi membrane [Cell Component]
Processing 00000000.tx.298: Yeast 16, 149-166.[CrossRef][Medline] De Camilli, P., Slepnev, V. 

Phrase: "Yeast 16,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "149-166."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Camilli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Slepnev,"

Phrase: "V."
Processing 00000000.tx.299: I., Shupliakov, O. and Brodin, L. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Shupliakov,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Brodin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.300: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.301: Synaptic vesicle endocytosis. 

Phrase: "Synaptic vesicle endocytosis."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1154462:synaptic vesicle endocytosis [Cell Function]
   901   C0014139:vesicle endocytosis [Cell Function]
           Endocytosis
   901   C0039065:Synaptic vesicle [Cell Component]
   827   C0333262:Vesicle [Acquired Abnormality]
   827   C1622418:vesicle [Cell Component]
   827   C2984285:Endocytosis [Functional Concept]
   755 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.302: In Synapse (ed. W. M. Cowan, T. C. Sudhof, C. F. Stevens and K. Davies), pp. 

Phrase: "In Synapse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039062:Synapse [Body Space or Junction]

Phrase: "(ed. W. M. Cowan,"

Phrase: "T. C. Sudhof,"

Phrase: "C. F. Stevens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551756:Stevens [Population Group]

Phrase: "and"

Phrase: "K. Davies"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.303: 217-274. 

Phrase: "217-274."
Processing 00000000.tx.304: Baltimore, MD: The Johns Hopkins University Press. 

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD"

Phrase: ":"

Phrase: "The Johns Hopkins University Press."
Processing 00000000.tx.305: Drummond, D. and Cross, R. 

Phrase: "Drummond,"

Phrase: "D."

Phrase: "and"

Phrase: "Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.307: Dynamics of interphase microtubules in Schizosaccharomyces pombe. 

Phrase: "Dynamics of interphase microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   802   C1156019:microtubule dynamics [Cell Function]

Phrase: "in Schizosaccharomyces pombe."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178453:Schizosaccharomyces pombe [Fungus]
   861   C0036361:Schizosaccharomyces [Fungus]
Processing 00000000.tx.308: Curr. 

Phrase: "Curr."
Processing 00000000.tx.309: Biol. 

Phrase: "Biol."
Processing 00000000.tx.310: 10, 766-775.[CrossRef][Medline] Engqvist-Goldstein, A. 

Phrase: "10,"

Phrase: "766-775."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Engqvist-Goldstein,"

Phrase: "A."
Processing 00000000.tx.311: E., Kessels, M. 

Phrase: "E.,"

Phrase: "Kessels,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.312: M., Chopra, V. 

Phrase: "M."

Phrase: ","

Phrase: "Chopra,"

Phrase: "V."
Processing 00000000.tx.313: S., Hayden, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hayden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.314: R. and Drubin, D. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.315: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.316: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.317: An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family is a novel component of clathrin-coated pits and vesicles. 

Phrase: "An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   780   C0759110:actin interacting protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C1421493:ACTIN-INTERACTING PROTEIN 1 [Gene or Genome]
   770   C0001239:Actin-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1149245:actin binding [Molecular Function]
   751 E C0033618:Protein Binding [Molecular Function]
   751   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "a novel component of clathrin-coated pits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.320: 147, 1503-1518.[Abstract/Free FullText] Engqvist-Goldstein, A. 

Phrase: "147,"

Phrase: "1503-1518."

Phrase: "[Abstract/Free FullText"

Phrase: "] Engqvist-Goldstein,"

Phrase: "A."
Processing 00000000.tx.321: E., Warren, R. 

Phrase: "E.,"

Phrase: "Warren,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.322: A., Kessels, M. 

Phrase: "A.,"

Phrase: "Kessels,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: M., Keen, J. 

Phrase: "M."

Phrase: ","

Phrase: "Keen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558083:Keen [Mental Process]

Phrase: "J."
Processing 00000000.tx.324: H., Heuser, J. and Drubin, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Heuser,"

Phrase: "J."

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.325: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.326: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.327: The actin-binding protein Hip1R associates with clathrin during early stages of endocytosis and promotes clathrin assembly in vitro. 

Phrase: "The actin-binding protein Hip1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1825475:HIP1R [Gene or Genome]
   756   C0001239:Actin-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associates with clathrin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "during early stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C2363430:early stages [Temporal Concept]
   983 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "clathrin assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.328: J. 

Phrase: "J."
Processing 00000000.tx.329: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.330: 154, 1209-1223.[Abstract/Free FullText] Ficarro, S. 

Phrase: "154,"

Phrase: "1209-1223."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ficarro,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.331: B., McCleland, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McCleland,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.332: L., Stukenberg, P. 

Phrase: "L., Stukenberg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.333: T., Burke, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Burke"

Phrase: ","

Phrase: "D."
Processing 00000000.tx.334: J., Ross, M. 

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: M., Shabanowitz, J., Hunt, D. 

Phrase: "M."

Phrase: ","

Phrase: "Shabanowitz,"

Phrase: "J.,"

Phrase: "Hunt,"

Phrase: "D."
Processing 00000000.tx.336: F. and White, F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.337: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.339: Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. 

Phrase: "Phosphoproteome analysis by mass spectrometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "its application to Saccharomyces cerevisiae."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.340: Nat. 

Phrase: "Nat."
Processing 00000000.tx.341: Biotechnol. 

Phrase: "Biotechnol."
Processing 00000000.tx.342: 20, 301-305.[CrossRef][Medline] Ford, M. 

Phrase: "20,"

Phrase: "301-305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.343: G., Pearse, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pearse,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.344: M., Higgins, M. 

Phrase: "M."

Phrase: ","

Phrase: "Higgins,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: K., Vallis, Y., Owen, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vallis,"

Phrase: "Y.,"

Phrase: "Owen,"

Phrase: "D."
Processing 00000000.tx.346: J., Gibson, A., Hopkins, C. 

Phrase: "J.,"

Phrase: "Gibson,"

Phrase: "A.,"

Phrase: "Hopkins,"

Phrase: "C."
Processing 00000000.tx.347: R., Evans, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Evans,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.348: R. and McMahon, H. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "McMahon,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.349: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.350: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.351: Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. 

Phrase: "Simultaneous binding of PtdIns(4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "clathrin by AP180"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the nucleation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1979936:Nucleated [Qualitative Concept]

Phrase: "of clathrin lattices"

Phrase: "on membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.352: Science 291, 1051-1055.[Abstract/Free FullText] Glynn, J. 

Phrase: "Science 291,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1051-1055."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450319:1051 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] Glynn,"

Phrase: "J."
Processing 00000000.tx.353: M., Lustig, R. 

Phrase: "M."

Phrase: ","

Phrase: "Lustig,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.354: J., Berlin, A. and Chang, F. 

Phrase: "J.,"

Phrase: "Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "A."

Phrase: "and"

Phrase: "Chang,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.355: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.356: Role of bud6p and tea1p in the interaction between actin and microtubules for the establishment of cell polarity in fission yeast. 

Phrase: "Role of bud6p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "tea1p in the interaction"

Phrase: "between actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "microtubules for the establishment of cell polarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026046:Microtubules [Cell Component]
   721   C1166786:polar microtubule [Cell Component]

Phrase: "in fission yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.357: Curr. 

Phrase: "Curr."
Processing 00000000.tx.358: Biol. 

Phrase: "Biol."
Processing 00000000.tx.359: 11, 836-845.[CrossRef][Medline] Gutekunst, C. 

Phrase: "11,"

Phrase: "836-845."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gutekunst,"

Phrase: "C."
Processing 00000000.tx.360: A., Levey, A. 

Phrase: "A.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.361: I., Heilman, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Heilman,"

Phrase: "C."
Processing 00000000.tx.362: J., Whaley, W. 

Phrase: "J.,"

Phrase: "Whaley,"

Phrase: "W."
Processing 00000000.tx.363: L., Yi, H., Nash, N. 

Phrase: "L., Yi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nash,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.364: R., Rees, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555622:Ree [Language]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.365: D., Madden, J. 

Phrase: "D."

Phrase: ","

Phrase: "Madden"

Phrase: ","

Phrase: "J."
Processing 00000000.tx.366: J. and Hersch, S. 

Phrase: "J."

Phrase: "and"

Phrase: "Hersch,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.367: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.369: Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "localization of huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "human lymphoblastoid cell lines with anti-fusion protein antibodies."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   781   C0682523:cell human lines [Cell]
   764   C0007600:Cell lines [Cell]
   762   C0007594:Cell Fusion [Laboratory Procedure]
   762   C0427861:cell human [Laboratory or Test Result]
   762   C1261468:Cell fusion [Cell Function]
   756   C0682526:lymphoblastoid cell line [Cell]
   742   C0007634:Cell [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.370: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.371: Natl. 

Phrase: "Natl."
Processing 00000000.tx.372: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.373: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.374: USA 92, 8710-8714.[Abstract/Free FullText] Hagan, I. 

Phrase: "USA 92,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "8710-8714."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hagan,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.375: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.377: The fission yeast microtubule cytoskeleton. 

Phrase: "The fission yeast microtubule cytoskeleton."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1166781:Microtubule cytoskeleton [Cell Component]
   812   C0010853:Cytoskeleton [Cell Component]
   812   C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.378: J. 

Phrase: "J."
Processing 00000000.tx.379: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.380: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.381: 111, 1603-1612.[Abstract/Free FullText] Hoffner, G., Kahlem, P. and Djian, P. 

Phrase: "111,"

Phrase: "1603-1612."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoffner,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kahlem,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Djian,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.382: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.383: Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. 

Phrase: "Perinuclear localization of huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of its binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "through an interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with beta-tubulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005290:beta-Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421231:TUBULIN, BETA [Gene or Genome]
  1000   C3539817:Tubulin, Beta [Amino Acid, Peptide, or Protein]
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C2937342:tubulin [Cell Component]

Phrase: ":"

Phrase: "relevance to Huntington's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.384: J. 

Phrase: "J."
Processing 00000000.tx.385: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.386: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.387: 115, 941-948.[Abstract/Free FullText] Holtzman, D. 

Phrase: "115,"

Phrase: "941-948."

Phrase: "[Abstract/Free FullText"

Phrase: "] Holtzman,"

Phrase: "D."
Processing 00000000.tx.388: A., Yang, S. and Drubin, D. 

Phrase: "A.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.389: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.390: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.391: Synthetic-lethal interactions identify two novel genes, SLA1 and SLA2, that control membrane cytoskeleton assembly in Saccharomyces cerevisiae. 

Phrase: "Synthetic-lethal interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "identify"

Phrase: "two novel genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "SLA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420083:SLA1 [Gene or Genome]

Phrase: "and"

Phrase: "SLA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424907:SLA2 [Gene or Genome]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "membrane cytoskeleton assembly in Saccharomyces cerevisiae."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0598838:membrane assembly [Cell Function]
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.394: 122, 635-644.[Abstract] Itoh, T., Koshiba, S., Kigawa, T., Kikuchi, A., Yokoyama, S. and Takenawa, T. 

Phrase: "122,"

Phrase: "635-644."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Itoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Koshiba,"

Phrase: "S."

Phrase: ","

Phrase: "Kigawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kikuchi,"

Phrase: "A.,"

Phrase: "Yokoyama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takenawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.395: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.396: Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. 

Phrase: "Role of the ENTH domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in phosphatidylinositol-4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "endocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]
Processing 00000000.tx.397: Science 291, 1047-1051.[Abstract/Free FullText] Iwaki, T., Tanaka, N., Takagi, H., Giga-Hama, Y. and Takegawa, K. 

Phrase: "Science 291,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1047-1051."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450319:1051 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] Iwaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takagi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Giga-Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1295018:HAMA [Laboratory Procedure]
   861   C3541258:HAMA [Intellectual Product]

Phrase: "Y."

Phrase: "and"

Phrase: "Takegawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.398: (2004). 

Phrase: "(2004"

Phrase: ")."
Processing 00000000.tx.399: Characterization of end4+, a gene required for endocytosis in Schizosaccharomyces pombe. 

Phrase: "Characterization of end4+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "required for endocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014139:Endocytosis [Cell Function]
   790   C1514873:Required [Functional Concept]
   790   C2984285:Endocytosis [Functional Concept]

Phrase: "in Schizosaccharomyces pombe."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178453:Schizosaccharomyces pombe [Fungus]
   861   C0036361:Schizosaccharomyces [Fungus]
Processing 00000000.tx.400: Yeast 21, 867-881.[CrossRef][Medline] Jin, H. and Amberg, D. 

Phrase: "Yeast 21,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "867-881."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jin,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Amberg,"

Phrase: "D."
Processing 00000000.tx.401: C. 

Phrase: "C."
Processing 00000000.tx.402: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.403: The secretory pathway mediates localization of the cell polarity regulator Aip3p/Bud6p. 

Phrase: "The secretory pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "localization of the cell polarity regulator Aip3p/Bud6p."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1660153:localisation of cell [Biologic Function]
           cell localization
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]
Processing 00000000.tx.404: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.405: Biol. 

Phrase: "Biol."
Processing 00000000.tx.406: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.407: 11, 647-661.[Abstract/Free FullText] Kaksonen, M., Sun, Y. and Drubin, D. 

Phrase: "11,"

Phrase: "647-661."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kaksonen,"

Phrase: "M."

Phrase: ","

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y."

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.408: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.410: A pathway for association of receptors, adaptors, and actin during endocytic internalization. 

Phrase: "A pathway for association of receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "adaptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706710:Adaptor [Manufactured Object]

Phrase: "and"

Phrase: "actin during endocytic internalization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.411: Cell 115, 475-487.[CrossRef][Medline] Kalchman, M. 

Phrase: "Cell 115,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "475-487."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kalchman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: A., Koide, H. 

Phrase: "A.,"

Phrase: "Koide,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.413: B., McCutcheon, K., Graham, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McCutcheon,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Graham,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.414: K., Nichol, K., Nishiyama, K., Kazemi-Esfarjani, P., Lynn, F. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nichol,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nishiyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kazemi-Esfarjani,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lynn,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.415: C., Wellington, C., Metzler, M. et al. 

Phrase: "C., Wellington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0453965:wellington [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Metzler,"

Phrase: "M. et al."
Processing 00000000.tx.416: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.417: HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. 

Phrase: "HIP1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121811:HIP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415546:HIP1 [Gene or Genome]
  1000   C2348977:HIP-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a human homologue of S. cerevisiae Sla2p,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homologue [Gene or Genome]

Phrase: "interacts with membrane-associated huntingtin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0025255:Membrane [Tissue]
   760   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1415504:HUNTINGTIN [Gene or Genome]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.418: Nat. 

Phrase: "Nat."
Processing 00000000.tx.419: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.420: 16, 44-53.[CrossRef][Medline] Marks, J. and Hyams, J. 

Phrase: "16,"

Phrase: "44-53."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "J."

Phrase: "and"

Phrase: "Hyams,"

Phrase: "J."
Processing 00000000.tx.421: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.422: (1985). 

Phrase: "(1985"

Phrase: ")."
Processing 00000000.tx.423: Localization of F-actin through the cell division cycle of Schizosaccharomyces pombe. 

Phrase: "Localization of F-actin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "through the cell division cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007586:Cell Division Cycle [Cell Function]
           Cell Cycle
   913   C1155839:Cell Cycle [Cell Function]
   827   C1511572:Cycle [Temporal Concept]
   734   C0007590:Cell division [Cell Function]

Phrase: "of Schizosaccharomyces pombe."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178453:Schizosaccharomyces pombe [Fungus]
   861   C0036361:Schizosaccharomyces [Fungus]
Processing 00000000.tx.424: Eur. 

Phrase: "Eur."
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.427: 39, 27-32. 

Phrase: "39,"

Phrase: "27-32."
Processing 00000000.tx.428: Mata, J. and Nurse, P. 

Phrase: "Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "J."

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.430: tea1 and the microtubular cytoskeleton are important for generating global spatial order within the fission yeast cell. 

Phrase: "tea1"

Phrase: "and"

Phrase: "the microtubular cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "are"

Phrase: "important for generating global spatial order"

Phrase: "within the fission yeast cell."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0178453:Yeast, Fission [Fungus]
   827   C0007634:Cell [Cell]
   827   C0036025:yeast [Fungus]
   827   C0043392:Yeast [Food]
   827   C0043393:Yeast [Fungus]
   827   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.431: Cell 89, 939-949.[CrossRef][Medline] McCann, R. 

Phrase: "Cell 89,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "939-949."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCann,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.432: O. and Craig, S. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: W. 

Phrase: "W."
Processing 00000000.tx.434: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.435: The I/LWEQ module: a conserved sequence that signifies F-actin binding in functionally diverse proteins from yeast to mammals. 

Phrase: "The I/LWEQ module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709061:Module [Conceptual Entity]
   727 E C1031041:Modulus [Eukaryote]

Phrase: ":"

Phrase: "a conserved"

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "signifies"

Phrase: "F-actin binding in functionally diverse proteins"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   840   C0059984:F-actin-binding proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1523040:F-actin binding [Molecular Function]
   804   C0001239:Actin-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1149245:actin binding [Molecular Function]
   774   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "from yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "to mammals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]
Processing 00000000.tx.436: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.437: Natl. 

Phrase: "Natl."
Processing 00000000.tx.438: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.439: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.440: USA 94, 5679-5684.[Abstract/Free FullText] McCann, R. 

Phrase: "USA 94,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "5679-5684."

Phrase: "[Abstract/Free FullText"

Phrase: "] McCann,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.441: O. and Craig, S. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.442: W. 

Phrase: "W."
Processing 00000000.tx.443: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.444: Functional genomic analysis reveals the utility of the I/LWEQ module as a predictor of protein:actin interaction. 

Phrase: "Functional genomic analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0558024:Functional analysis [Health Care Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the utility of the I/LWEQ module"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0582205:utility [Organization]

Phrase: "as a predictor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698872:Predictor [Idea or Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "actin interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.445: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.446: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.447: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.448: Commun. 

Phrase: "Commun."
Processing 00000000.tx.449: 266, 135-140.[CrossRef][Medline] Mishra, S. 

Phrase: "266,"

Phrase: "135-140."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mishra,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.450: K., Agostinelli, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Agostinelli,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.451: R., Brett, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Brett,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.452: J., Mizukami, I., Ross, T. 

Phrase: "J.,"

Phrase: "Mizukami,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.453: S. and Traub, L. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Traub,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.454: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.456: Clathrin- and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins. 

Phrase: "Clathrin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "AP-2-binding sites in HIP1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0005456:Binding Sites [Receptor]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Sites [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "uncover"

Phrase: "a general assembly role for endocytic accessory proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.457: J. 

Phrase: "J."
Processing 00000000.tx.458: Biol. 

Phrase: "Biol."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 276, 46230-46236.[Abstract/Free FullText] Mitchison, J. 

Phrase: "276,"

Phrase: "46230-46236."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mitchison,"

Phrase: "J."
Processing 00000000.tx.461: M. and Nurse, P. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.462: (1985). 

Phrase: "(1985"

Phrase: ")."
Processing 00000000.tx.463: Growth in cell length in the fission yeast Schizosaccharomyces pombe. 

Phrase: "Growth in cell length in the fission yeast Schizosaccharomyces pombe."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0424639:length growth [Finding]
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.464: J. 

Phrase: "J."
Processing 00000000.tx.465: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.466: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.467: 75, 357-376.[Abstract] Moreno, S., Klar, A. and Nurse, P. 

Phrase: "75,"

Phrase: "357-376."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Moreno,"

Phrase: "S."

Phrase: ","

Phrase: "Klar,"

Phrase: "A."

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.468: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.469: Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. 

Phrase: "Molecular genetic analysis of fission yeast Schizosaccharomyces pombe."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.470: Methods Enzymol. 

Phrase: "Methods Enzymol."
Processing 00000000.tx.471: 194, 795-823.[Medline] Muchowski, P. 

Phrase: "194,"

Phrase: "795-823."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muchowski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.472: J., Ning, K., D'Souza-Schorey, C. and Fields, S. 

Phrase: "J.,"

Phrase: "Ning,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "D'"

Phrase: "Souza-Schorey,"

Phrase: "C."

Phrase: "and"

Phrase: "Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.473: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.474: Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. 

Phrase: "Requirement of an intact microtubule cytoskeleton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]

Phrase: "for aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "inclusion body formation by a mutant huntingtin fragment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.475: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.476: Natl. 

Phrase: "Natl."
Processing 00000000.tx.477: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.478: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.479: USA 99, 727-732.[Abstract/Free FullText] Pardo, M. and Nurse, P. 

Phrase: "USA 99,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "727-732."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pardo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.480: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.481: Equatorial retention of the contractile actin ring by microtubules during cytokinesis. 

Phrase: "Equatorial retention of the contractile actin ring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035280:Retention [Mental Process]
   748   C0333117:Retention [Functional Concept]
   748   C1753315:retention [Cell Function]

Phrase: "by microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "during cytokinesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010813:Cytokinesis [Cell Function]
  1000   C1330957:cytokinesis [Cell Function]
Processing 00000000.tx.482: Science 300, 1569-1574.[Abstract/Free FullText] Raths, S., Rohrer, J., Crausaz, F. and Riezman, H. 

Phrase: "Science 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1569-1574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Raths,"

Phrase: "S."

Phrase: ","

Phrase: "Rohrer,"

Phrase: "J.,"

Phrase: "Crausaz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Riezman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.483: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.484: end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. 

Phrase: "end3"

Phrase: "and"

Phrase: "end4"

Phrase: ":"

Phrase: "two mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "defective in receptor-mediated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "and"

Phrase: "fluid-phase endocytosis in Saccharomyces cerevisiae."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0031945:fluid-phase endocytosis [Cell Function]
   753   C0005889:FLUID [Body Substance]
   753   C0014139:Endocytosis [Cell Function]
   753   C0205390:Phase [Temporal Concept]
   753   C0302908:fluid [Substance]
   753   C0444611:Fluid [Qualitative Concept]
   753   C1704353:Fluid [Substance]
   753   C2984285:Endocytosis [Functional Concept]
Processing 00000000.tx.485: J. 

Phrase: "J."
Processing 00000000.tx.486: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.487: 120, 55-65.[Abstract] Riezman, H. 

Phrase: "120,"

Phrase: "55-65."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C0450385:65 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Riezman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.488: (1985). 

Phrase: "(1985"

Phrase: ")."
Processing 00000000.tx.489: Endocytosis in yeast: several of the yeast secretory mutants are defective in endocytosis. 

Phrase: "Endocytosis in yeast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014139:Endocytosis [Cell Function]
   790   C2984285:Endocytosis [Functional Concept]

Phrase: ":"

Phrase: "several of the yeast secretory mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439064:Several [Quantitative Concept]
   753   C0443302:Several [Quantitative Concept]

Phrase: "are"

Phrase: "defective in endocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332452:Defective [Functional Concept]
Processing 00000000.tx.490: Cell 40, 1001-1009.[CrossRef][Medline] Rupes, I., Jia, Z. and Young, P. 

Phrase: "Cell 40,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0439509:/40 [Temporal Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1001-1009."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rupes,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jia,"

Phrase: "Z."

Phrase: "and"

Phrase: "Young, P."
Processing 00000000.tx.491: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.492: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.493: Ssp1 promotes actin depolymerization and is involved in stress response and new end take-off control in fission yeast. 

Phrase: "Ssp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1427200:SSP1 [Gene or Genome]
  1000   C3273783:SSP1 [Gene or Genome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "actin depolymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1155980:actin depolymerization [Cell Function]
   861   C0301644:Depolymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "involved in stress response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0149784:stress response [Physiologic Function]
   770   C0038435:Stress [Finding]
   770   C0871261:Response [Organism Attribute]
   770   C1314939:Involved [Functional Concept]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "new end take-off control in fission yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.494: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: Cell 10, 1495-1510.[Abstract/Free FullText] Sawin, K. 

Phrase: "Cell 10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1495-1510."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sawin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.497: E. and Nurse, P. 

Phrase: "E."

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.498: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.499: Regulation of cell polarity by microtubules in fission yeast. 

Phrase: "Regulation of cell polarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "in fission yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.500: J. 

Phrase: "J."
Processing 00000000.tx.501: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.502: 142, 457-471.[Abstract/Free FullText] Snell, V. and Nurse, P. 

Phrase: "142,"

Phrase: "457-471."

Phrase: "[Abstract/Free FullText"

Phrase: "] Snell,"

Phrase: "V."

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.503: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.504: Genetic analysis of cell morphogenesis in fission yeast  a role for casein kinase II in the establishment of polarized growth. 

Phrase: "Genetic analysis of cell morphogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in fission yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178453:Yeast, Fission [Fungus]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "a role for casein kinase II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the establishment"

Phrase: "of polarized growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.505: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.506: 13, 2066-2074.[Abstract] Sun, J. 

Phrase: "13,"

Phrase: "2066-2074."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "J."
Processing 00000000.tx.507: Y., Wu, X. 

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "X."
Processing 00000000.tx.508: S. and Wu, L. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.509: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.510: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.511: Single and multiple vesicle fusion induce different rates of endocytosis at a central synapse. 

Phrase: "Single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "multiple vesicle fusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1326474:vesicle fusion [Cell Function]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "different rates of endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "at a central synapse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039062:Synapse [Body Space or Junction]
Processing 00000000.tx.512: Nature 417, 555-559.[CrossRef][Medline] Tukamoto, T., Nukina, N., Ide, K. and Kanazawa, I. 

Phrase: "Nature 417,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "555-559."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tukamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.513: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.514: Huntington's disease gene product, huntingtin, associates with microtubules in vitro. 

Phrase: "Huntington's disease gene product,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0872189:Huntington gene [Gene or Genome]
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "huntingtin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "associates with microtubules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026046:Microtubules [Cell Component]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.515: Brain. 

Phrase: "Brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.516: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.517: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.518: Brain. 

Phrase: "Brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.519: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.520: 51, 8-14.[Medline] Verde, F., Mata, J. and Nurse, P. 

Phrase: "51,"

Phrase: "8-14."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Verde,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "J."

Phrase: "and"

Phrase: "Nurse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028661:Nurse [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.521: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.522: Fission yeast cell morphogenesis: identification of new genes and analysis of their role during the cell cycle. 

Phrase: "Fission yeast cell morphogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1156238:cell morphogenesis [Cell Function]
   812   C0026559:Morphogenesis [Organism Function]

Phrase: ":"

Phrase: "identification of new genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "analysis of their role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "during the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.523: J. 

Phrase: "J."
Processing 00000000.tx.524: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.525: 131, 1529-1538.[Abstract] Wanker, E. 

Phrase: "131,"

Phrase: "1529-1538."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wanker,"

Phrase: "E."
Processing 00000000.tx.526: E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J. and Lehrach, H. 

Phrase: "E.,"

Phrase: "Rovira,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Scherzinger,"

Phrase: "E.,"

Phrase: "Hasenbank,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Walter,"

Phrase: "S."

Phrase: ","

Phrase: "Tait,"

Phrase: "D."

Phrase: ","

Phrase: "Colicelli,"

Phrase: "J."

Phrase: "and"

Phrase: "Lehrach,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.527: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.528: HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. 

Phrase: "HIP-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121811:HIP-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "a huntingtin interacting protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated by the yeast two-hybrid system."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   853   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
   853   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   748   C0020205:Hybrid [Organism]
   748   C0036025:yeast [Fungus]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0205409:Isolated [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0449913:System [Functional Concept]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1548221:Isolated [Idea or Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.529: Hum. 

Phrase: "Hum."
Processing 00000000.tx.530: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.531: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.532: 6, 487-495.[Abstract/Free FullText] Wesp, A., Hicke, L., Palecek, J., Lombardi, R., Aust, T., Munn, A. 

Phrase: "6,"

Phrase: "487-495."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wesp,"

Phrase: "A.,"

Phrase: "Hicke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Palecek,"

Phrase: "J.,"

Phrase: "Lombardi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Aust,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Munn,"

Phrase: "A."
Processing 00000000.tx.533: L. and Riezman, H. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riezman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.534: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.535: End4p/Sla2p interacts with actin-associated proteins for endocytosis in Saccharomyces cerevisiae. 

Phrase: "End4p/Sla2p"

Phrase: "interacts with actin-associated proteins"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "in Saccharomyces cerevisiae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036025:Saccharomyces cerevisae [Fungus]
   861   C0036024:Saccharomyces [Fungus]
Processing 00000000.tx.536: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.537: Biol. 

Phrase: "Biol."
Processing 00000000.tx.538: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.539: 8, 2291-2306.[Abstract/Free FullText] Yang, S., Ayscough, K. 

Phrase: "8,"

Phrase: "2291-2306."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."

Phrase: ","

Phrase: "Ayscough,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.540: R. and Drubin, D. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.541: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.542: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.543: A role for the actin cytoskeleton of Saccharomyces cerevisiae in bipolar bud-site selection. 

Phrase: "A role for the actin cytoskeleton of Saccharomyces cerevisiae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in bipolar bud-site selection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1155624:bipolar bud site selection [Cell Function]
   812   C0036576:selection [Genetic Function]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2700462:Bud [Plant]
   812   C2825164:Site [Spatial Concept]
   812   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.544: J. 

Phrase: "J."
Processing 00000000.tx.545: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.546: 136, 111-123.[Abstract/Free FullText] Yang, S., Cope, M. 

Phrase: "136,"

Phrase: "111-123."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."

Phrase: ","

Phrase: "Cope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009967:cope [Individual Behavior]

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.547: J. and Drubin, D. 

Phrase: "J."

Phrase: "and"

Phrase: "Drubin,"

Phrase: "D."
Processing 00000000.tx.548: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.549: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.550: Sla2p is associated with the yeast cortical actin cytoskeleton via redundant localization signals. 

Phrase: "Sla2p"

Phrase: "is"

Phrase: "associated with the yeast cortical actin cytoskeleton"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   814   C1325547:Cortical actin cytoskeleton [Cell Component]
   778   C0025979:Actin Cytoskeleton [Cell Component]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1325546:Cortical cytoskeleton [Cell Component]
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001613:Cortical [Body Part, Organ, or Organ Component]
   748   C0007776:Cortical [Body Part, Organ, or Organ Component]
   748   C0010853:Cytoskeleton [Cell Component]
   748   C0022655:Cortical [Body Part, Organ, or Organ Component]
   748   C0036025:yeast [Fungus]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1748451:Cytoskeleton [Cell Component]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "via redundant localization signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.551: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.552: Biol. 

Phrase: "Biol."
Processing 00000000.tx.553: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.554: 10, 2265-2283.[Abstract/Free FullText]

Phrase: "10,"

Phrase: "2265-2283."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

